Publications

Publications published since 2010 from OUS - Department of Oncology

1528 publications found (only first 1000 shown)

Publications 2019

  1. Abrahamsson H, Porojnicu AC, Lindstrøm JC, Dueland S, Flatmark K, Hole KH, Seierstad T, Moan J, Redalen KR, Meltzer S, Ree AH (2019)
    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
    BMC Cancer, 19 (1), 488
    DOI 10.1186/s12885-019-5724-z, PubMed 31122213
  2. Abravan A, Eide HA, Løndalen AM, Helland Å, Malinen E (2019)
    Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer
    Mol Imaging Biol, 21 (2), 391-398
    DOI 10.1007/s11307-018-1226-7, PubMed 29916117
  3. Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2019)
    Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors
    J Natl Compr Canc Netw, 17 (5), 459-468
    DOI 10.6004/jnccn.2018.7109, PubMed 31085753
  4. Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2019)
    Second cancers in patients with locally advanced prostate cancer randomized to lifelong endocrine treatment with or without radical radiotherapy. Long term follow- up of the Scandinavian Prostate Cancer Group-7 trial
    Int J Radiat Oncol Biol Phys (in press)
    DOI 10.1016/j.ijrobp.2019.11.027, PubMed 31786279
  5. Alkodsi A, Cervera A, Zhang K, Louhimo R, Meriranta L, Pasanen A, Leivonen SK, Holte H, Leppä S, Lehtonen R, Hautaniemi S (2019)
    Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes
    Leukemia, 33 (11), 2662-2672
    DOI 10.1038/s41375-019-0509-6, PubMed 31186494
  6. Alrehily F, Hogg P, Twiste M, Johansen S, Tootell A (2019)
    Scoliosis imaging: An analysis of radiation risk in the CT scan projection radiograph and a comparison with projection radiography and EOS
    Radiography (Lond), 25 (3), e68-e74
    DOI 10.1016/j.radi.2019.02.005, PubMed 31301794
  7. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G, Jackson C, McClure C, Woods RR, Saint-Jacques N, Morgan E, Ransom D, Thursfield V, Møller B, Leonfellner S, Guren MG, Bray F, Arnold M (2019)
    Changes in colorectal cancer incidence in seven high-income countries: a population-based study
    Lancet Gastroenterol Hepatol, 4 (7), 511-518
    DOI 10.1016/S2468-1253(19)30147-5, PubMed 31105047
  8. Bai B, Vodák D, Nakken S, Wise JF, Blaker YN, Lingjærde OC, Brodtkorb M, Hilden V, Trøen G, Lorenz S, Lawrence MS, Myklebost O, Meza-Zepeda L, Beiske K, Hovig E, Smeland EB, Holte H, Myklebust JH (2019)
    Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma
    Blood, 134 (Supplement_1), 20
    DOI 10.1182/blood-2019-128403, PubMed 31723999
  9. Bains SJ, Niehusmann PF, Meling TR, Saxhaug C, Züchner M, Brandal P (2019)
    Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease-a case report and literature review
    Acta Neurochir (Wien), 161 (2), 343-349
    DOI 10.1007/s00701-019-03800-z, PubMed 30652202
  10. Balstad TR, Bye A, Jenssen CR, Solheim TS, Thoresen L, Sand K (2019)
    Patient interpretation of the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form
    Patient Prefer Adherence, 13, 1391-1400
    DOI 10.2147/PPA.S204188, PubMed 31496666
  11. Ben-Aharon I, Goshen-Lago T, Fontana E, Smyth E, Guren M, Caballero C, Lordick F (2019)
    Social networks for young patients with cancer: the time for system agility
    Lancet Oncol, 20 (6), 765
    DOI 10.1016/S1470-2045(19)30346-8, PubMed 31162090
  12. Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede RD, IASP Taskforce for the Classification of Chronic Pain (2019)
    The IASP classification of chronic pain for ICD-11: chronic cancer-related pain
    Pain, 160 (1), 38-44
    DOI 10.1097/j.pain.0000000000001363, PubMed 30586069
  13. Bergholtz H, Lien TG, Ursin G, Holmen MM, Helland Å, Sørlie T, Haakensen VD (2019)
    A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue
    J Mammary Gland Biol Neoplasia, 24 (2), 163-175
    DOI 10.1007/s10911-018-09423-x, PubMed 30613869
  14. Bernard P, Savard J, Steindorf K, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvao DA, Chinapaw MJ, Stuiver MM, Griffith KA, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schmidt ME, Ulrich CM, Sonke GS, van Harten W, Winters-Stone KM, Velthuis MJ, Taaffe DR et al. (2019)
    Effects and moderators of exercise on sleep in adults with cancer: Individual patient data and aggregated meta-analyses
    J Psychosom Res, 124, 109746
    DOI 10.1016/j.jpsychores.2019.109746, PubMed 31443811
  15. Berner K, Bruland ØS (2019)
    Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
    Anticancer Res, 39 (5), 2459-2466
    DOI 10.21873/anticanres.13365, PubMed 31092440
  16. Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Seland M, Wilsgaard T, Smeland KB, Kiserud CE (2019)
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-019-0745-4, PubMed 31745250
  17. Bersvendsen HS, Haugnes HS, Fagerli UM, Fluge Ø, Holte H, Smeland KB, Wilsgaard T, Kiserud CE (2019)
    Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
    Acta Oncol, 58 (5), 690-699
    DOI 10.1080/0284186X.2018.1558370, PubMed 30696346
  18. Biccler JL, Glimelius I, Eloranta S, Smeland KB, Brown PN, Jakobsen LH, Frederiksen H, Jerkeman M, Fosså A, Andersson TML, Holte H, Bøgsted M, El-Galaly TC, Smedby KE (2019)
    Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
    J Clin Oncol, 37 (9), 703-713
    DOI 10.1200/JCO.18.01652, PubMed 30726176
  19. Bishop MR, Maziarz RT, Waller EK, Jäger U, Westin JR, McGuirk JP, Fleury I, Holte H, Borchmann P, Del Corral C, Tiwari R, Anak Ö, Awasthi R, Pacaud L, Romanov VV, Schuster SJ (2019)
    Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion
    Blood Adv, 3 (14), 2230-2236
    DOI 10.1182/bloodadvances.2019000151, PubMed 31332046
  20. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605
  21. Bonsaksen T, Heir T, Ekeberg Ø, Grimholt TK, Lerdal A, Skogstad L, Schou-Bredal I (2019)
    Self-evaluated anxiety in the Norwegian population: prevalence and associated factors
    Arch Public Health, 77, 10
    DOI 10.1186/s13690-019-0338-0, PubMed 30923612
  22. Bowitz Lothe IM, Kleive D, Pomianowska E, Cvancarova M, Kure E, Dueland S, Gladhaug IP, Labori KJ (2019)
    Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy
    Pancreatology, 19 (2), 316-324
    DOI 10.1016/j.pan.2019.01.019, PubMed 30713128
  23. Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M (2019)
    Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma
    J Laryngol Otol, 133 (6), 508-514
    DOI 10.1017/S0022215119000677, PubMed 31006407
  24. Brunsell TH, Cengija V, Sveen A, Bjørnbeth BA, Røsok BI, Brudvik KW, Guren MG, Lothe RA, Abildgaard A, Nesbakken A (2019)
    Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
    Eur J Surg Oncol, 45 (12), 2340-2346
    DOI 10.1016/j.ejso.2019.07.017, PubMed 31350075
  25. Bucher-Johannessen C, Page CM, Haugen TB, Wojewodzic MW, Fosså SD, Grotmol T, Haugnes HS, Rounge TB (2019)
    Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
    Clin Epigenetics, 11 (1), 179
    DOI 10.1186/s13148-019-0764-4, PubMed 31796056
  26. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019)
    Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
    Lancet, 394 (10212), 1915-1928
    DOI 10.1016/S0140-6736(19)32591-7, PubMed 31679945
  27. Bøhn SH, Thorsen L, Kiserud CE, Fosså SD, Lie HC, Loge JH, Wisløff T, Haugnes HS, Reinertsen KV (2019)
    Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
    Acta Oncol, 58 (5), 753-762
    DOI 10.1080/0284186X.2018.1557344, PubMed 30696351
  28. Camilio KA, Wang MY, Mauseth B, Waagene S, Kvalheim G, Rekdal Ø, Sveinbjørnsson B, Mælandsmo GM (2019)
    Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
    Breast Cancer Res, 21 (1), 9
    DOI 10.1186/s13058-018-1092-x, PubMed 30670061
  29. Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE (2019)
    Employment Status and Work Ability in Long-Term Young Adult Cancer Survivors
    J Adolesc Young Adult Oncol, 8 (3), 304-311
    DOI 10.1089/jayao.2018.0109, PubMed 30900929
  30. Debik J, Euceda LR, Lundgren S, Gythfeldt HVL, Garred Ø, Borgen E, Engebraaten O, Bathen TF, Giskeødegård GF (2019)
    Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients
    J Proteome Res, 18 (10), 3649-3660
    DOI 10.1021/acs.jproteome.9b00316, PubMed 31483662
  31. Dolan RD, Laird BJA, Klepstad P, Kaasa S, Horgan PG, Paulsen Ø, McMillan DC (2019)
    An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
    Medicine (Baltimore), 98 (37), e17019
    DOI 10.1097/MD.0000000000017019, PubMed 31517821
  32. Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, Behrens S, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Canzian F, Chan TL et al. (2019)
    Two truncating variants in FANCC and breast cancer risk
    Sci Rep, 9 (1), 12524
    DOI 10.1038/s41598-019-48804-y, PubMed 31467304
  33. El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME (2019)
    Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
    Clin Cancer Res, 25 (13), 4104-4116
    DOI 10.1158/1078-0432.CCR-18-3179, PubMed 30952644
  34. Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL et al. (2019)
    Genome-wide association study of germline variants and breast cancer-specific mortality
    Br J Cancer, 120 (6), 647-657
    DOI 10.1038/s41416-019-0393-x, PubMed 30787463
  35. Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J (2019)
    DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
    Acta Oncol, 58 (10), 1502-1505
    DOI 10.1080/0284186X.2019.1629012, PubMed 31282236
  36. Falstie-Jensen AM, Kjærsgaard A, Lorenzen EL, Jensen JD, Reinertsen KV, Dekkers OM, Ewertz M, Cronin-Fenton DP (2019)
    Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study
    Breast Cancer Res, 21 (1), 44
    DOI 10.1186/s13058-019-1122-3, PubMed 30902106
  37. Fauske L, Bondevik H, Ahlberg K, Bjørndal A (2019)
    Identifying bone sarcoma survivors facing psychosocial challenges. A study of trajectories following treatment
    Eur J Cancer Care (Engl), 28 (5), e13119
    DOI 10.1111/ecc.13119, PubMed 31184795
  38. Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS (2019)
    Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study
    Clin Sarcoma Res, 9, 6
    DOI 10.1186/s13569-019-0116-3, PubMed 31061697
  39. Faye-Schjøll HH, Schou-Bredal I (2019)
    Pessimism predicts anxiety and depression in breast cancer survivors: A 5-year follow-up study
    Psychooncology, 28 (6), 1314-1320
    DOI 10.1002/pon.5084, PubMed 30950120
  40. Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, Gomez da Silva M, Santoro A et al. (2019)
    KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
    Haematologica (in press)
    DOI 10.3324/haematol.2018.214056, PubMed 31537689
  41. Fosså A, Smeland K, Fagerli UM, Galleberg RB, Bersvendsen HS, Holte H (2019)
    Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016
    Acta Oncol
    DOI 10.1080/0284186X.2019.1652765, PubMed 31429371
  42. Fosså SD, Beyer B, Dahl AA, Aas K, Eri LM, Kvan E, Falk RS, Graefen M, Huland H, Berge V (2019)
    Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique
    Scand J Urol, 1-7 (in press)
    DOI 10.1080/21681805.2019.1693625, PubMed 31797716
  43. Fredheim OMS, Kaasa S, C Borchgrevink P (2019)
    Smertebehandling ved kronisk kreftsykdom
    Tidsskr Nor Laegeforen, 139 (13)
    DOI 10.4045/tidsskr.19.0226, PubMed 31556529
  44. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2019)
    ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
    Eur J Surg Oncol (in press)
    DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394
  45. Fung C, Dinh PC, Fossa SD, Travis LB (2019)
    Testicular Cancer Survivorship
    J Natl Compr Canc Netw, 17 (12), 1557-1568
    DOI 10.6004/jnccn.2019.7369, PubMed 31805527
  46. Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2019)
    Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol (in press)
    DOI 10.1016/j.euo.2019.08.002, PubMed 31506250
  47. Gjerset GM, Kiserud CE, Loge JH, Fosså SD, Wisløff T, Gudbergsson SB, Oldervoll LM, Thorsen L (2019)
    Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors
    Acta Oncol, 58 (5), 682-689
    DOI 10.1080/0284186X.2018.1562210, PubMed 30862228
  48. Gjerset GM, Tendille M, Skaali T, Kiserud CE, Dahl AA, Gudbergsson SB, Thorsen L (2019)
    Gender differences in health status and benefits of a one-week educational programme for caregivers of cancer patients
    Eur J Cancer Care (Engl), 28 (2), e12992
    DOI 10.1111/ecc.12992, PubMed 30652372
  49. Grimholt TK, Bonsaksen T, Schou-Bredal I, Heir T, Lerdal A, Skogstad L, Ekeberg Ø (2019)
    Flight Anxiety Reported from 1986 to 2015
    Aerosp Med Hum Perform, 90 (4), 384-388
    DOI 10.3357/AMHP.5125.2019, PubMed 30922426
  50. Grov EK, Dahl AA (2019)
    Golf as Therapy for Individuals With Mental Health or Substance Use Disorders
    J Psychosoc Nurs Ment Health Serv, 57 (10), 44-51
    DOI 10.3928/02793695-20190528-02, PubMed 31188463
  51. Grønberg BH, Valan CD, Halvorsen T, Sjøblom B, Jordhøy MS (2019)
    Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients
    J Cachexia Sarcopenia Muscle, 10 (6), 1347-1355
    DOI 10.1002/jcsm.12469, PubMed 31385663
  52. Guren MG (2019)
    The global challenge of colorectal cancer
    Lancet Gastroenterol Hepatol, 4 (12), 894-895
    DOI 10.1016/S2468-1253(19)30329-2, PubMed 31648973
  53. Hamfjord J, Guren TK, Dajani O, Johansen JS, Glimelius B, Sorbye H, Pfeiffer P, Lingjærde OC, Tveit KM, Kure EH, Pallisgaard N, Spindler KG (2019)
    Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
    Ann Oncol, 30 (7), 1088-1095
    DOI 10.1093/annonc/mdz139, PubMed 31046124
  54. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
    Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
    Int J Med Inform, 125, 102-109
    DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174
  55. Heir T, Bonsaksen T, Grimholt T, Ekeberg Ø, Skogstad L, Lerdal A, Schou-Bredal I (2019)
    Serious life events and post-traumatic stress disorder in the Norwegian population
    BJPsych Open, 5 (5), e82
    DOI 10.1192/bjo.2019.62, PubMed 31506124
  56. Hellesnes R, Kvammen Ø, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2019)
    Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    Int J Cancer
    DOI 10.1002/ijc.32704, PubMed 31597192
  57. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2019)
    Older persons' experiences of adapting to daily life at home after hospital discharge: a qualitative metasummary
    BMC Health Serv Res, 19 (1), 224
    DOI 10.1186/s12913-019-4035-z, PubMed 30975144
  58. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2019)
    Healthcare professionals' experiences of providing individualized nutritional care for Older People in hospital and home care: a qualitative study
    BMC Geriatr, 19 (1), 317
    DOI 10.1186/s12877-019-1339-0, PubMed 31747884
  59. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
    Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
    Lancet Oncol, 20 (3), e155-e166
    DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059
  60. Høghaug G, Skår R, Tran TN, Schou-Bredal I (2019)
    Nurses' experiences with newly acquired knowledge about medication management: A qualitative study
    J Nurs Manag, 27 (8), 1731-1737
    DOI 10.1111/jonm.12864, PubMed 31495022
  61. Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
    Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
    Ann Surg Oncol, 26 (13), 4730-4736
    DOI 10.1245/s10434-019-07813-x, PubMed 31520212
  62. Hølmebakk T, Boye K (2019)
    Author response to comment on: Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
    Br J Surg, 106 (8), 1102-1103
    DOI 10.1002/bjs.11245, PubMed 31260582
  63. Jakobsen G, Engstrøm M, Thronæs M, Løhre ET, Kaasa S, Fayers P, Hjermstad MJ, Klepstad P (2019)
    Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphy
    Support Care Cancer (in press)
    DOI 10.1007/s00520-019-04998-5, PubMed 31392550
  64. Jansen YJL, Rozeman EA, Mason R, Goldinger SM, Geukes Foppen MH, Hoejberg L, Schmidt H, van Thienen JV, Haanen JBAG, Tiainen L, Svane IM, Mäkelä S, Seremet T, Arance A, Dummer R, Bastholt L, Nyakas M, Straume O, Menzies AM, Long GV, Atkinson V, Blank CU, Neyns B (2019)
    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
    Ann Oncol, 30 (7), 1154-1161
    DOI 10.1093/annonc/mdz110, PubMed 30923820
  65. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
    Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
    J Glob Oncol, 5, 1-10
    DOI 10.1200/JGO.19.00015, PubMed 30917070
  66. Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF et al. (2019)
    Breast cancer quantitative proteome and proteogenomic landscape
    Nat Commun, 10 (1), 1600
    DOI 10.1038/s41467-019-09018-y, PubMed 30962452
  67. Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH (2019)
    TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
    Cancer Immunol Res, 7 (3), 355-362
    DOI 10.1158/2326-6066.CIR-18-0351, PubMed 30659053
  68. Kirkhus L, Harneshaug M, Šaltytė Benth J, Grønberg BH, Rostoft S, Bergh S, Hjermstad MJ, Selbæk G, Wyller TB, Kirkevold Ø, Borza T, Saltvedt I, Jordhøy MS (2019)
    Modifiable factors affecting older patients' quality of life and physical function during cancer treatment
    J Geriatr Oncol, 10 (6), 904-912
    DOI 10.1016/j.jgo.2019.08.001, PubMed 31444088
  69. Kirkhus L, Šaltytė Benth J, Grønberg BH, Hjermstad MJ, Rostoft S, Harneshaug M, Selbæk G, Wyller TB, Jordhøy MS (2019)
    Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study
    Palliat Med, 33 (3), 312-322
    DOI 10.1177/0269216319825972, PubMed 30712456
  70. Kirkhus L, Šaltytė Benth J, Grønberg BH, Hjermstad MJ, Rostoft S, Harneshaug M, Selbæk G, Wyller TB, Slaaen M (2019)
    Reply to the letter to the editor 'Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care'
    Palliat Med, UNSP 0269216319888987
    DOI 10.1177/0269216319888987, PubMed 31739739
  71. Kryeziu K, Bruun J, Guren TK, Sveen A, Lothe RA (2019)
    Combination therapies with HSP90 inhibitors against colorectal cancer
    Biochim Biophys Acta Rev Cancer, 1871 (2), 240-247
    DOI 10.1016/j.bbcan.2019.01.002, PubMed 30708039
  72. Kvael LAH, Debesay J, Bye A, Bergland A (2019)
    Health-care professionals' experiences of patient participation among older patients in intermediate care-At the intersection between profession, market and bureaucracy
    Health Expect, 22 (5), 921-930
    DOI 10.1111/hex.12896, PubMed 31127681
  73. Kvåle R, Myklebust TÅ, Fosså SD, Aas K, Ekanger C, Helle SI, Honoré A, Møller B (2019)
    Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients
    Prostate, 79 (16), 1852-1860
    DOI 10.1002/pros.23911, PubMed 31566779
  74. Kyte JA, Fåne A, Pule M, Gaudernack G (2019)
    Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
    Oncoimmunology, 8 (4), e1565236
    DOI 10.1080/2162402X.2019.1565236, PubMed 30906659
  75. Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2019)
    Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
    Blood Adv, 3 (8), 1230-1243
    DOI 10.1182/bloodadvances.2018029678, PubMed 30979721
  76. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
    Treating osteosarcoma with CAR T cells
    Scand J Immunol, 89 (3), e12741
    DOI 10.1111/sji.12741, PubMed 30549299
  77. Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D (2019)
    No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
    Br J Haematol (in press)
    DOI 10.1111/bjh.16232, PubMed 31612478
  78. Lai X, Geier OM, Fleischer T, Garred Ø, Borgen E, Funke SW, Kumar S, Rognes ME, Seierstad T, Børresen-Dale AL, Kristensen VN, Engebraaten O, Köhn-Luque A, Frigessi A (2019)
    Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data
    Cancer Res, 79 (16), 4293-4304
    DOI 10.1158/0008-5472.CAN-18-1804, PubMed 31118201
  79. Landmark T, Romundstad P, Butler S, Kaasa S, Borchgrevink P (2019)
    Development and course of chronic widespread pain: the role of time and pain characteristics (the HUNT pain study)
    Pain, 160 (9), 1976-1981
    DOI 10.1097/j.pain.0000000000001585, PubMed 30985619
  80. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
    Neuroradiology, 61 (5), 545-555
    DOI 10.1007/s00234-019-02173-5, PubMed 30712139
  81. Lie HC, Rueegg CS, Fosså SD, Loge JH, Ruud E, Kiserud CE (2019)
    Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the NOR-CAYACS study
    J Cancer Surviv, 13 (3), 353-363
    DOI 10.1007/s11764-019-00757-x, PubMed 30993649
  82. Lilleby O, Hernes E, Lilleby W (2019)
    Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
    Urol Case Rep, 27, 100992
    DOI 10.1016/j.eucr.2019.100992, PubMed 31453108
  83. Lilleheie I, Debesay J, Bye A, Bergland A (2019)
    Experiences of elderly patients regarding participation in their hospital discharge: a qualitative metasummary
    BMJ Open, 9 (11), e025789
    DOI 10.1136/bmjopen-2018-025789, PubMed 31685492
  84. Lindholm EM, Ragle Aure M, Haugen MH, Kleivi Sahlberg K, Kristensen VN, Nebdal D, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2019)
    miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
    Mol Oncol, 13 (10), 2278-2296
    DOI 10.1002/1878-0261.12561, PubMed 31402562
  85. Lockmer S, Ren W, Brodtkorb M, Østenstad B, Wahlin BE, Pan-Hammarström Q, Kimby E (2019)
    M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
    Br J Haematol
    DOI 10.1111/bjh.16159, PubMed 31423576
  86. Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
    Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Cold Spring Harb Mol Case Stud, 5 (2)
    DOI 10.1101/mcs.a003566, PubMed 30862609
  87. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
    Acta Neurochir (Wien), 161 (9), 1793-1798
    DOI 10.1007/s00701-019-04014-z, PubMed 31309304
  88. Lundar T, Due-Tønnessen BJ, Frič R, Krossnes B, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Neurosurgical treatment of pediatric pleomorphic xanthoastrocytomas: long-term follow-up of a single-institution, consecutive series of 12 patients
    J Neurosurg Pediatr, 23 (4), 512-516
    DOI 10.3171/2018.11.PEDS18449, PubMed 30738389
  89. Lunde P, Bye A, Bergland A, Nilsson BB (2019)
    Effects of individualized follow-up with a smartphone-application after cardiac rehabilitation: protocol of a randomized controlled trial
    BMC Sports Sci Med Rehabil, 11, 34
    DOI 10.1186/s13102-019-0148-2, PubMed 31768261
  90. Lunde P, Nilsson BB, Bergland A, Bye A (2019)
    Feasibility of a Mobile Phone App to Promote Adherence to a Heart-Healthy Lifestyle: Single-Arm Study
    JMIR Form Res, 3 (2), e12679
    DOI 10.2196/12679, PubMed 31066684
  91. Løhre ET, Thronæs M, Brunelli C, Kaasa S, Klepstad P (2019)
    An in-hospital clinical care pathway with integrated decision support for cancer pain management reduced pain intensity and needs for hospital stay
    Support Care Cancer (in press)
    DOI 10.1007/s00520-019-04836-8, PubMed 31123870
  92. Mahmood JI, Grotmol KS, Tesli M, Moum T, Andreassen O, Tyssen R (2019)
    Life satisfaction in Norwegian medical doctors: a 15-year longitudinal study of work-related predictors
    BMC Health Serv Res, 19 (1), 729
    DOI 10.1186/s12913-019-4599-7, PubMed 31640717
  93. Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2019)
    Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
    Transl Oncol, 12 (8), 1038-1044
    DOI 10.1016/j.tranon.2019.04.014, PubMed 31146167
  94. Mensali N, Dillard P, Hebeisen M, Lorenz S, Theodossiou T, Myhre MR, Fåne A, Gaudernack G, Kvalheim G, Myklebust JH, Inderberg EM, Wälchli S (2019)
    NK cells specifically TCR-dressed to kill cancer cells
    EBioMedicine, 40, 106-117
    DOI 10.1016/j.ebiom.2019.01.031, PubMed 30665853
  95. Mensali N, Grenov A, Pati NB, Dillard P, Myhre MR, Gaudernack G, Kvalheim G, Inderberg EM, Bakke O, Wälchli S (2019)
    Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
    Oncoimmunology, 8 (3), 1558663
    DOI 10.1080/2162402X.2018.1558663, PubMed 30723591
  96. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2019)
    Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 68 (8), 1235-1243
    DOI 10.1007/s00262-019-02356-2, PubMed 31214732
  97. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2019)
    Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother (in press)
    DOI 10.1007/s00262-019-02409-6, PubMed 31776597
  98. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
    The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
    Radiother Oncol, 140, 54-61
    DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
  99. Maaland AF, Heyerdahl H, O'Shea A, Eiriksdottir B, Pascal V, Andersen JT, Kolstad A, Dahle J (2019)
    Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003
    Eur J Nucl Med Mol Imaging, 46 (11), 2311-2321
    DOI 10.1007/s00259-019-04417-1, PubMed 31309259
  100. Nabel CS, Sameroff S, Shilling D, Alapat D, Ruth JR, Kawano M, Sato Y, Stone K, Spetalen S, Valdivieso F, Feldman MD, Chadburn A, Fosså A, van Rhee F, Lipkin WI, Fajgenbaum DC (2019)
    Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease
    PLoS One, 14 (6), e0218660
    DOI 10.1371/journal.pone.0218660, PubMed 31242229
  101. Namløs HM, Boye K, Meza-Zepeda LA (2019)
    Cell-free DNA in blood as a noninvasive insight into the sarcoma genome
    Mol Aspects Med (in press)
    DOI 10.1016/j.mam.2019.10.004, PubMed 31703948
  102. Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R et al. (2019)
    Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
    Eur J Cancer, 119, 168-178
    DOI 10.1016/j.ejca.2019.07.010, PubMed 31445199
  103. Nilssen Y, Brustugun OT, Tandberg Eriksen M, Gulbrandsen J, Skaaheim Haug E, Naume B, Møller B (2019)
    Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway
    Cancer Epidemiol, 61, 59-69
    DOI 10.1016/j.canep.2019.05.004, PubMed 31153048
  104. Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM, EMBRACE Collaborative Group (2019)
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
    Radiother Oncol, 134, 185-190
    DOI 10.1016/j.radonc.2019.02.007, PubMed 31005214
  105. Nome ME, Euceda LR, Jabeen S, Debik J, Bathen TF, Giskeødegård GF, Taskén KA, Maelandsmo GM, Halvorsen B, Yndestad A, Borgen E, Garred Ø, Aukrust P, Ueland T, Engebraaten O, Kristensen VN, Tekpli X (2019)
    Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
    Int J Cancer, 146 (1), 223-235
    DOI 10.1002/ijc.32638, PubMed 31444972
  106. Nordvik Ø, Heggdal POL, Brännström JK, Hjermstad MJ, Aarstad AK, Aarstad HJ (2019)
    Quality of life in persons with hearing loss: a study of patients referred to an audiological service
    Int J Audiol, 58 (11), 696-703
    DOI 10.1080/14992027.2019.1627010, PubMed 31195860
  107. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
    Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Clin Exp Immunol, 197 (1), 74-82
    DOI 10.1111/cei.13283, PubMed 30821848
  108. Nygård S, Lingjærde OC, Caldas C, Hovig E, Børresen-Dale AL, Helland Å, Haakensen VD (2019)
    PathTracer: High-sensitivity detection of differential pathway activity in tumours
    Sci Rep, 9 (1), 16332
    DOI 10.1038/s41598-019-52529-3, PubMed 31704995
  109. Olsen JA, Brunborg C, Steinberg M, Persse D, Sterz F, Lozano M, Westfall M, van Grunsven PM, Lerner EB, Wik L (2019)
    Survival to hospital discharge with biphasic fixed 360 joules versus 200 escalating to 360 joules defibrillation strategies in out-of-hospital cardiac arrest of presumed cardiac etiology
    Resuscitation, 136, 112-118
    DOI 10.1016/j.resuscitation.2019.01.020, PubMed 30708074
  110. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
    The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
    Eur Thyroid J, 8 (3), 159-166
    DOI 10.1159/000499018, PubMed 31259158
  111. Ricchini F, Caraceni A, Zecca E, Pigni A, Centurioni F, Manzoni A, Kaasa S, Brunelli C (2019)
    Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial
    J Pain Symptom Manage, 58 (4), 587-595
    DOI 10.1016/j.jpainsymman.2019.06.016, PubMed 31233843
  112. Richartz N, Duthil E, Ford A, Naderi EH, Bhagwat S, Gilljam KM, Burman MM, Ruud E, Blomhoff HK, Skah S (2019)
    Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model
    Blood Adv, 3 (21), 3181-3190
    DOI 10.1182/bloodadvances.2019000473, PubMed 31698450
  113. Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
    MRI in the Follow-up of Testicular Cancer: Less is More
    Anticancer Res, 39 (6), 2963-2968
    DOI 10.21873/anticanres.13427, PubMed 31177136
  114. Rusten E, Rekstad BL, Undseth C, Klotz D, Hernes E, Guren MG, Malinen E (2019)
    Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
    Br J Radiol, 92 (1097), 20181006
    DOI 10.1259/bjr.20181006, PubMed 30810343
  115. Røen I, Stifoss-Hanssen H, Grande G, Kaasa S, Sand K, Knudsen AK (2019)
    Supporting carers: health care professionals in need of system improvements and education - a qualitative study
    BMC Palliat Care, 18 (1), 58
    DOI 10.1186/s12904-019-0444-3, PubMed 31311536
  116. Röhrl K, Guren MG, Astrup GL, Småstuen MC, Rustøen T (2019)
    High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study
    Eur J Oncol Nurs, 44, 101679 (in press)
    DOI 10.1016/j.ejon.2019.101679, PubMed 31751848
  117. Röhrl K, Guren MG, Småstuen MC, Rustøen T (2019)
    Symptoms during chemotherapy in colorectal cancer patients
    Support Care Cancer, 27 (8), 3007-3017
    DOI 10.1007/s00520-018-4598-y, PubMed 30607676
  118. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM et al. (2019)
    Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
    Eur Urol (in press)
    DOI 10.1016/j.eururo.2019.03.022, PubMed 30992160
  119. Sandmael JA, Sand K, Bye A, Solheim TS, Oldervoll L, Helvik AS (2019)
    Nutritional experiences in head and neck cancer patients
    Eur J Cancer Care (Engl), 28 (6), e13168
    DOI 10.1111/ecc.13168, PubMed 31571296
  120. Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R et al. (2019)
    Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)
    Eur J Cancer, 121, 144-153
    DOI 10.1016/j.ejca.2019.08.014, PubMed 31581055
  121. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavandʼhomme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, Rice ASC, Rowbotham MC, Schug S et al. (2019)
    The IASP classification of chronic pain for ICD-11: chronic neuropathic pain
    Pain, 160 (1), 53-59
    DOI 10.1097/j.pain.0000000000001365, PubMed 30586071
  122. Schou-Bredal I, Bonsaksen T, Heir T, Skogstad L, Lerdal A, Grimholt T, Ekeberg O (2019)
    Optimists report fewer physical and mental health conditions than pessimists in the general Norwegian population
    HEALTH PSYCHOL. REP., 7 (1), 9-18
  123. Shao B, Bjaanæs MM, Helland Å, Schütte C, Conrad T (2019)
    EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma
    PLoS One, 14 (1), e0204186
    DOI 10.1371/journal.pone.0204186, PubMed 30703089
  124. Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W, Breast Cancer Association Consortium (2019)
    Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
    Int J Epidemiol, 48 (3), 795-806
    DOI 10.1093/ije/dyy201, PubMed 30277539
  125. Sigurdardottir KR, Hjermstad MJ, Filbet M, Tricou C, McQuillan R, Costantini M, Autelitano C, Bennett MI, Haugen DF (2019)
    Pilot testing of the first version of the European Association for Palliative Care basic dataset: A mixed methods study
    Palliat Med, 33 (7), 832-849
    DOI 10.1177/0269216319844439, PubMed 31023149
  126. Simensen VC, Smeland KB, Kiserud CE, Dahl AA, Bersvendsen HS, Fluge Ø, Fagerli UM, Fosså A (2019)
    Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma
    Acta Oncol, 58 (9), 1315-1322
    DOI 10.1080/0284186X.2019.1637538, PubMed 31286808
  127. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
    Head Neck, 41 (6), 1725-1737
    DOI 10.1002/hed.25609, PubMed 30636188
  128. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE (2019)
    Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients
    Bone Marrow Transplant, 54 (12), 2102-2109
    DOI 10.1038/s41409-019-0638-6, PubMed 31455897
  129. Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA (2019)
    Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
    ESMO Open, 4 (3), e000523
    DOI 10.1136/esmoopen-2019-000523, PubMed 31321083
  130. Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA (2019)
    Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Oncogenesis, 8 (6), 35
    DOI 10.1038/s41389-019-0141-3, PubMed 31092812
  131. Smedman TM, Guren TK, Line PD, Dueland S (2019)
    Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study
    Transpl Int, 32 (11), 1144-1150
    DOI 10.1111/tri.13471, PubMed 31209941
  132. Solberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, Helland Å, Hjelde HH, Jakobsen B, Møller B, Petersen M, Strand TE, Wahl SGF, Aanerud M, Fjellbirkeland L (2019)
    Increase in curative treatment and survival of lung cancer in Norway 2001-2016
    Eur J Epidemiol, 34 (10), 951-955
    DOI 10.1007/s10654-019-00536-z, PubMed 31313073
  133. Stankovic B, Bjørhovde HAK, Skarshaug R, Aamodt H, Frafjord A, Müller E, Hammarström C, Beraki K, Bækkevold ES, Woldbæk PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A (2019)
    Immune Cell Composition in Human Non-small Cell Lung Cancer
    Front Immunol, 9, 3101
    DOI 10.3389/fimmu.2018.03101, PubMed 30774636
  134. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496
  135. Stene GB, Balstad TR, Leer ASM, Bye A, Kaasa S, Fallon M, Laird B, Maddocks M, Solheim TS (2019)
    Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia
    Cancers (Basel), 11 (12)
    DOI 10.3390/cancers11121925, PubMed 31816924
  136. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
  137. Stewart R, Fosså SD, Hotopf M, Mykletun A (2019)
    Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study
    Br J Psychiatry, 1-7 (in press)
    DOI 10.1192/bjp.2019.211, PubMed 31587671
  138. Stikbakke E, Richardsen E, Knutsen T, Wilsgaard T, Giovannucci EL, McTiernan A, Eggen AE, Haugnes HS, Thune I (2019)
    Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study
    Int J Cancer
    DOI 10.1002/ijc.32718, PubMed 31583707
  139. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
  140. Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy069, PubMed 30084992
  141. Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Ajengui A, Lundell L, Lagergren P, Nilsson M (2019)
    Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
    Br J Surg, 106 (11), 1452-1463
    DOI 10.1002/bjs.11246, PubMed 31436322
  142. Switlyk MD, Salberg UB, Geier OM, Vlatkovic L, Lilleby W, Lyng H, Seierstad T (2019)
    PTEN Expression in Prostate Cancer: Relationship With Clinicopathologic Features and Multiparametric MRI Findings
    AJR Am J Roentgenol, 212 (6), 1206-1214
    DOI 10.2214/AJR.18.20743, PubMed 30888866
  143. Switlyk MD, Skeie AT, Lund-Iversen M, Østenstad B (2019)
    Magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma
    Ann Hematol (in press)
    DOI 10.1007/s00277-019-03850-4, PubMed 31768676
  144. Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø, OSBREAC, Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN (2019)
    An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
    Nat Commun, 10 (1), 5499
    DOI 10.1038/s41467-019-13329-5, PubMed 31796750
  145. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
    Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
    NPJ Breast Cancer, 5, 13
    DOI 10.1038/s41523-019-0108-8, PubMed 30993194
  146. Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T, Viset T, Norum OJ, Bruland Ø, Zaikova O (2019)
    Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
    Acta Oncol, 58 (3), 273-282
    DOI 10.1080/0284186X.2018.1554260, PubMed 30632866
  147. Thronæs M, Balstad TR, Brunelli C, Løhre ET, Klepstad P, Vagnildhaug OM, Kaasa S, Knudsen AK, Solheim TS (2019)
    Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?
    Support Care Cancer (in press)
    DOI 10.1007/s00520-019-04981-0, PubMed 31290020
  148. Torper J, Ansteinsson V, Lundeby T (2019)
    Moving the four habits model into dentistry. Development of a dental consultation model: Do dentists need an additional habit?
    Eur J Dent Educ, 23 (2), 220-229
    DOI 10.1111/eje.12421, PubMed 30659766
  149. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavandʼhomme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ (2019)
    Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
    Pain, 160 (1), 19-27
    DOI 10.1097/j.pain.0000000000001384, PubMed 30586067
  150. Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME (2019)
    Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
    Clin Cancer Res, 25 (19), 5913-5924
    DOI 10.1158/1078-0432.CCR-19-0113, PubMed 31296530
  151. Tøndel H, Solberg A, Lydersen S, Jensen CA, Kaasa S, Lund JÅ (2019)
    Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer
    Clin Transl Radiat Oncol, 15, 113-117
    DOI 10.1016/j.ctro.2019.02.003, PubMed 30834350
  152. Vagnildhaug OM, Brunelli C, Hjermstad MJ, Strasser F, Baracos V, Wilcock A, Nabal M, Kaasa S, Laird B, Solheim TS (2019)
    A prospective study examining cachexia predictors in patients with incurable cancer
    BMC Palliat Care, 18 (1), 46
    DOI 10.1186/s12904-019-0429-2, PubMed 31164115
  153. van Vulpen JK, Sweegers MG, Peeters PHM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Galvão DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Mesters I, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL et al. (2019)
    Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data
    Med Sci Sports Exerc (in press)
    DOI 10.1249/MSS.0000000000002154, PubMed 31524827
  154. Verkissen MN, Hjermstad MJ, Van Belle S, Kaasa S, Deliens L, Pardon K (2019)
    Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study
    PLoS One, 14 (10), e0222988
    DOI 10.1371/journal.pone.0222988, PubMed 31596849
  155. von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy078, PubMed 30137281
  156. Zucca E, Rondeau S, Vanazzi A, Østenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Lohri A, Novak U, Zander T, Bersvendsen H, Bargetzi M, Mingrone W, Krasniqi F, Dirnhofer S, Hayoz S, Hawle H, Vilei SB, Ghielmini M et al. (2019)
    Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
    Blood, 134 (4), 353-362
    DOI 10.1182/blood-2018-10-879643, PubMed 31101627

Publications 2018

  1. Ahlgren GM, Flodgren P, Tammela TLJ, Kellokumpu-Lehtinen P, Borre M, Angelsen A, Iversen JR, Sverrisdottir A, Jonsson E, Sengelov L, Investigators of the Scandinavian Prostate Cancer Study Number 12 (2018)
    Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
    Eur Urol, 73 (6), 870-876
    DOI 10.1016/j.eururo.2018.01.012, PubMed 29395502
  2. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
    SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
    Radiother Oncol, 128 (2), 192-197
    DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847
  3. Ali AS, Grönberg M, Langer SW, Ladekarl M, Hjortland GO, Vestermark LW, Österlund P, Welin S, Grønbæk H, Knigge U, Sorbye H, Janson ET (2018)
    Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
    Med Oncol, 35 (4), 47
    DOI 10.1007/s12032-018-1103-x, PubMed 29511910
  4. Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M (2018)
    Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
    Cancer Treat Rev, 66, 23-44
    DOI 10.1016/j.ctrv.2018.03.005, PubMed 29673922
  5. Baekelandt BMG, Fagerland MW, Hjermstad MJ, Heiberg T, Labori KJ, Buanes TA (2018)
    Survival, Complications and Patient Reported Outcomes after Pancreatic Surgery
    HPB (Oxford), 21 (3), 275-282
    DOI 10.1016/j.hpb.2018.07.023, PubMed 30120002
  6. Belfrage A, Grotmol KS, Tyssen R, Moum T, Lien L (2018)
    Factors associated with low vs increased perceived mastery of clinical work over ten years of practice: a prospective study of Norwegian doctors
    BMC Med Educ, 18 (1), 116
    DOI 10.1186/s12909-018-1236-9, PubMed 29843695
  7. Belfrage ASV, Grotmol KS, Tyssen R, Moum T, Finset A, Isaksson Rø K, Lien L (2018)
    Factors influencing doctors' counselling on patients' lifestyle habits: a cohort study
    BJGP Open, 2 (3), bjgpopen18X101607
    DOI 10.3399/bjgpopen18X101607, PubMed 30564740
  8. Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, Iversen LH, Schnell EA, Lundqvist K, Christensen J, Morris M, Coleman MP, Walters S (2018)
    Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
    Lancet Oncol, 20 (1), 74-87
    DOI 10.1016/S1470-2045(18)30646-6, PubMed 30545752
  9. Berger O, Grønberg BH, Loge JH, Kaasa S, Sand K (2018)
    Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study
    BMC Cancer, 18 (1), 381
    DOI 10.1186/s12885-018-4164-5, PubMed 29614997
  10. Berner K, Johannesen TB, Hall KS, Bruland ØS (2018)
    Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
    J Bone Oncol, 14, 002-2
    DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
  11. Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS (2018)
    Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
    J Surg Oncol, 118 (1), 246-247
    DOI 10.1002/jso.25137, PubMed 30208205
  12. Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W et al. (2018)
    Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
    J Natl Cancer Inst, 110 (6), 560-567
    DOI 10.1093/jnci/djy018, PubMed 29659933
  13. Bjørnelv GMW, Dueland S, Line PD, Joranger P, Fretland ÅA, Edwin B, Sørbye H, Aas E (2018)
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver
    Br J Surg, 106 (1), 132-141
    DOI 10.1002/bjs.10962, PubMed 30325494
  14. Boland JW, Allgar V, Boland EG, Kaasa S, Hjermstad MJ, Johnson MJ (2018)
    Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
    Palliat Med, 33 (2), 206-212
    DOI 10.1177/0269216318811011, PubMed 30404572
  15. Bonsaksen T, Grimholt TK, Skogstad L, Lerdal A, Ekeberg Ø, Heir T, Schou-Bredal I (2018)
    Self-diagnosed depression in the Norwegian general population - associations with neuroticism, extraversion, optimism, and general self-efficacy
    BMC Public Health, 18 (1), 1076
    DOI 10.1186/s12889-018-5990-8, PubMed 30157827
  16. Bonsaksen T, Lerdal A, Heir T, Ekeberg Ø, Skogstad L, Grimholt TK, Schou-Bredal I (2018)
    General self-efficacy in the Norwegian population: Differences and similarities between sociodemographic groups
    Scand J Public Health, 1403494818756701 (in press)
    DOI 10.1177/1403494818756701, PubMed 29417880
  17. Borchmann P, Fosså A, Długosz-Danecka M, Böll B, Dietlein M, Kobe C, Goergen H, Engert A (2018)
    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered
    Hemasphere, 2 (3), e52
    DOI 10.1097/HS9.0000000000000052, PubMed 31723777
  18. Borgen E, Rypdal MC, Sosa MS, Renolen A, Schlichting E, Lønning PE, Synnestvedt M, Aguirre-Ghiso JA, Naume B (2018)
    NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
    Breast Cancer Res, 20 (1), 120
    DOI 10.1186/s13058-018-1049-0, PubMed 30322396
  19. Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2018)
    Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
    Transl Oncol, 12 (1), 76-83
    DOI 10.1016/j.tranon.2018.09.010, PubMed 30273860
  20. Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
    Genotype and risk of tumour rupture in gastrointestinal stromal tumour
    Br J Surg, 105 (2), e169-e175
    DOI 10.1002/bjs.10743, PubMed 29341147
  21. Boysen AK, Sørensen BS, Lefevre AC, Abrantes R, Johansen JS, Jensen BV, Schou JV, Larsen FO, Nielsen D, Taflin H, Gustavson B, Wettergren Y, Sorensen BS, Ree AH, Dueland S, Pallisgaard N, Spindler KL (2018)
    Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer
    Clin Chim Acta, 487, 107-111
    DOI 10.1016/j.cca.2018.09.029, PubMed 30240586
  22. Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
    Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
    Nutr J, 17 (1), 94
    DOI 10.1186/s12937-018-0402-6, PubMed 30333016
  23. Brustugun OT, Grønberg BH, Fjellbirkeland L, Helbekkmo N, Aanerud M, Grimsrud TK, Helland Å, Møller B, Nilssen Y, Strand TE, Solberg SK (2018)
    Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016
    Lung Cancer, 122, 138-145
    DOI 10.1016/j.lungcan.2018.06.003, PubMed 30032822
  24. Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA (2018)
    Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
    Mol Oncol, 12 (9), 1639-1655
    DOI 10.1002/1878-0261.12347, PubMed 29900672
  25. Brændengen M, Glimelius B (2018)
    Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved? An update of the "Nordic" LARC study in non-resectable cancers
    Radiother Oncol, 127 (3), 392-395
    DOI 10.1016/j.radonc.2018.05.004, PubMed 29778486
  26. Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG (2018)
    Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
    Acta Oncol, 57 (9), 1159-1164
    DOI 10.1080/0284186X.2018.1464664, PubMed 29771169
  27. Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvão DA, Aaronson NK, Stuiver MM, Jacobsen PB, Verdonck-de Leeuw IM, Steindorf K, Irwin ML, Hayes S, Griffith KA, Lucia A, Herrero-Roman F, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M et al. (2018)
    Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis
    J Natl Cancer Inst, 110 (11), 1190-1200
    DOI 10.1093/jnci/djy161, PubMed 30299508
  28. Bøhn SH, Fosså SD, Wisløff T, Thorsen L (2018)
    Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
    Support Care Cancer, 27 (3), 1001-1011
    DOI 10.1007/s00520-018-4389-5, PubMed 30094728
  29. Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A (2018)
    Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
    Eur J Cancer, 101, 236-243
    DOI 10.1016/j.ejca.2018.06.034, PubMed 30096704
  30. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T et al. (2018)
    Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv51-iv67
    DOI 10.1093/annonc/mdy096, PubMed 29846498
  31. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T et al. (2018)
    Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv68-iv78
    DOI 10.1093/annonc/mdy095, PubMed 29846513
  32. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S et al. (2018)
    Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv79-iv95
    DOI 10.1093/annonc/mdy310, PubMed 30285218
  33. Claassen YHM, Bastiaannet E, Hartgrink HH, Dikken JL, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Lindblad M, Hedberg J, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Koessler T, Chevallay M, Allum WH, van de Velde CJH (2018)
    International comparison of treatment strategy and survival in metastatic gastric cancer
    BJS Open, 3 (1), 56-61
    DOI 10.1002/bjs5.103, PubMed 30734016
  34. Claassen YHM, Dikken JL, Hartgrink HH, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Johansson J, Rouvelas I, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Allum WH, Portielje JEA, Bastiaannet E, van de Velde CJH (2018)
    North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis
    Eur J Surg Oncol, 44 (12), 1982-1989
    DOI 10.1016/j.ejso.2018.09.014, PubMed 30343998
  35. Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E (2018)
    Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison
    Br J Cancer, 119 (4), 517-522
    DOI 10.1038/s41416-018-0215-6, PubMed 30057408
  36. Da Broi M, Jahr G, Beiske K, Holte H, Meling TR (2018)
    Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL
    Blood Cells Mol Dis, 73, 25-32
    DOI 10.1016/j.bcmd.2018.08.005, PubMed 30217760
  37. Dale E, Waldeland E (2018)
    Proton therapy - a reality in Norway from 2023
    Tidsskr Nor Laegeforen, 138 (13)
    DOI 10.4045/tidsskr.18.0250, PubMed 30180494
  38. Davidson B, Bjørnerem M, Holth A, Hellesylt E, Hetland Falkenthal TE, Flørenes VA (2018)
    Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma
    Gynecol Oncol, 150 (1), 136-142
    DOI 10.1016/j.ygyno.2018.05.007, PubMed 29804637
  39. Davidson B, Holth A, Wang Z, Hellsylt E, Tropé CG, Hetland Falkenthal TE, Holm R (2018)
    Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma
    APMIS, 126 (4), 309-313
    DOI 10.1111/apm.12816, PubMed 29464778
  40. Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplant, 53 (5), 657-660
    DOI 10.1038/s41409-018-0091-y, PubMed 29358600
  41. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
    Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
    Adv Radiat Oncol, 3 (4), 559-567
    DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
  42. Dillard P, Köksal H, Inderberg EM, Wälchli S (2018)
    A Spheroid Killing Assay by CAR T Cells
    J Vis Exp (142)
    DOI 10.3791/58785, PubMed 30596389
  43. Dueland S, Foss A, Solheim JM, Hagness M, Line PD (2018)
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma
    Br J Surg, 105 (6), 736-742
    DOI 10.1002/bjs.10769, PubMed 29532908
  44. Dueland S, Line PD, Hagness M, Foss A, Andersen MH (2018)
    Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver
    BJS Open, 3 (2), 180-185
    DOI 10.1002/bjs5.50116, PubMed 30957065
  45. Eichenauer DA, André M, Johnson P, Fossa A, Casasnovas O, Engert A (2018)
    Controversies in the Treatment of Classical Hodgkin Lymphoma
    Hemasphere, 2 (5), e149
    DOI 10.1097/HS9.0000000000000149, PubMed 30887012
  46. Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å (2018)
    Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
    Adv Radiat Oncol, 3 (2), 130-138
    DOI 10.1016/j.adro.2017.12.007, PubMed 29904737
  47. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  48. Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Pedersen LB, Geisler CH, Jerkeman M, Grønbæk K (2018)
    Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
    Haematologica, 103 (11), e541-e543
    DOI 10.3324/haematol.2018.194399, PubMed 29794145
  49. Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T et al. (2018)
    Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
    Lancet Haematol, 5 (8), e359-e367
    DOI 10.1016/S2352-3026(18)30090-5, PubMed 30078408
  50. Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD, Platinum Study Group (2018)
    Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
    Clin Genitourin Cancer, 16 (4), e761-e769
    DOI 10.1016/j.clgc.2018.01.011, PubMed 29534941
  51. Filippov-Levy N, Cohen-Schussheim H, Tropé CG, Hetland Falkenthal TE, Smith Y, Davidson B, Reich R (2018)
    Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
    Gynecol Oncol, 148 (3), 559-566
    DOI 10.1016/j.ygyno.2018.01.004, PubMed 29310950
  52. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, Jürgenliemk-Schulz IM, Segedin B, Tan LT, Hoskin P, Mahantshetty U, Bruheim K, Rai B, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group (2018)
    Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies
    Int J Radiat Oncol Biol Phys, 103 (4), 887-894
    DOI 10.1016/j.ijrobp.2018.11.006, PubMed 30419309
  53. Fossa SD, Fung C, Dahl AA (2018)
    Late adverse outcomes after treatment of testicular cancer
    Onkologe, 24 2, S104-S109
  54. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P et al. (2018)
    Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
    JAMA Oncol, 4 (9), e180219
    DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
  55. Froehlich K, Stensheim H, Markert UR, Turowski G (2018)
    Breast carcinoma in pregnancy with spheroid-like placental metastases-a case report
    APMIS, 126 (5), 448-452
    DOI 10.1111/apm.12827, PubMed 29665170
  56. Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB (2018)
    Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
    Adv Urol, 2018, 8671832
    DOI 10.1155/2018/8671832, PubMed 29670654
  57. Gandara DR, von Pawel J, Mazieres J, Sullivan R, Helland Å, Han JY, Ponce Aix S, Rittmeyer A, Barlesi F, Kubo T, Park K, Goldschmidt J, Gandhi M, Yun C, Yu W, Matheny C, He P, Sandler A, Ballinger M, Fehrenbacher L (2018)
    Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
    J Thorac Oncol, 13 (12), 1906-1918
    DOI 10.1016/j.jtho.2018.08.2027, PubMed 30217492
  58. George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM et al. (2018)
    Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
    Nat Commun, 9 (1), 1048
    DOI 10.1038/s41467-018-03099-x, PubMed 29535388
  59. Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Fosså A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Körholz D et al. (2018)
    18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
    J Nucl Med, 59 (10), 1524-1530
    DOI 10.2967/jnumed.117.205633, PubMed 29653979
  60. Grotmol KS, Lie HC, Loge JH, Aass N, Haugen DF, Stone PC, Kaasa S, Hjermstad MJ (2018)
    Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients
    Palliat Support Care, 17 (2), PII S1478951517001183-149
    DOI 10.1017/S1478951517001183, PubMed 29317008
  61. Grut H, Revheim ME, Line PD, Dueland S (2018)
    Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
    Nucl Med Commun, 39 (7), 621-627
    DOI 10.1097/MNM.0000000000000843, PubMed 29683930
  62. Grønberg BH, Sjøblom B, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Bye A, Jordhøy M (2018)
    A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer
    Eur J Clin Nutr, 73 (7), 1069-1076
    DOI 10.1038/s41430-018-0325-5, PubMed 30254241
  63. Guren MG, Aagnes B, Nygård M, Dahl O, Møller B (2018)
    Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
    Clin Colorectal Cancer, 18 (1), e96-e103
    DOI 10.1016/j.clcc.2018.10.001, PubMed 30415990
  64. Habberstad R, Frøseth TCS, Aass N, Abramova T, Baas T, Mørkeset ST, Caraceni A, Laird B, Boland JW, Rossi R, Garcia-Alonso E, Stensheim H, Loge JH, Hjermstad MJ, Bjerkeset E, Bye A, Lund JÅ, Solheim TS, Vagnildhaug OM, Brunelli C, Damås JK, Mollnes TE, Kaasa S, Klepstad P (2018)
    The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
    BMC Palliat Care, 17 (1), 110
    DOI 10.1186/s12904-018-0362-9, PubMed 30266081
  65. Habberstad R, Hjermstad MJ, Brunelli C, Kaasa S, Bennett MI, Pardon K, Klepstad P (2018)
    Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses
    Support Care Cancer, 27 (4), 1335-1343
    DOI 10.1007/s00520-018-4405-9, PubMed 30105665
  66. Halvorsen AR, Sandhu V, Sprauten M, Flote VG, Kure EH, Brustugun OT, Helland Å (2018)
    Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
    Acta Oncol, 57 (9), 1225-1231
    DOI 10.1080/0284186X.2018.1465585, PubMed 29683761
  67. Haugnes HS, Stenklev NC, Brydøy M, Dahl O, Wilsgaard T, Laukli E, Fosså SD (2018)
    Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
    Acta Oncol, 57 (8), 1075-1083
    DOI 10.1080/0284186X.2018.1433323, PubMed 29384420
  68. Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W (2018)
    Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
    Urol Oncol, 37 (4), 289.e19-289.e26
    DOI 10.1016/j.urolonc.2018.09.016, PubMed 30446451
  69. Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O (2018)
    Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
    Future Oncol, 14 (24), 2543-2556
    DOI 10.2217/fon-2018-0087, PubMed 29925281
  70. Helland A (2018)
    Groundbreaking basic research
    Tidsskr. Nor. Laegeforen., 138 (20), 1905
  71. Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P (2018)
    Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
    J Bone Oncol, 14, 100216
    DOI 10.1016/j.jbo.2018.100216, PubMed 30666289
  72. Hjelle LV, Gundersen POM, Hellesnes R, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Bremnes RM, Haugnes HS (2018)
    Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Acta Oncol, 57 (10), 1392-1400
    DOI 10.1080/0284186X.2018.1473641, PubMed 29775128
  73. Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G, NORCCAP Study Group† (2018)
    Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial
    Ann Intern Med, 168 (11), 775-782
    DOI 10.7326/M17-1441, PubMed 29710125
  74. Holte H, Beiske K, Boyle M, Trøen G, Blaker YN, Myklebust J, Kvaløy S, Rosenwald A, Lingjaerde OC, Rimsza LM, Smeland EB, Scott DW, Kolstad A (2018)
    The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy
    Br J Haematol, 183 (2), 225-234
    DOI 10.1111/bjh.15518, PubMed 30080252
  75. Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann KP, Fizazi K, Fosså S, Germa-Lluch JR, Giannatempo P, Gietema JA, Gillessen S, Haugnes HS, Heidenreich A, Hemminki K, Huddart R, Jewett MAS, Joly F, Lauritsen J, Lorch A, Necchi A et al. (2018)
    ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
    Ann Oncol, 29 (8), 1658-1686
    DOI 10.1093/annonc/mdy217, PubMed 30113631
  76. Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G (2018)
    Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
    Ann Surg (in press)
    DOI 10.1097/SLA.0000000000003035, PubMed 30216219
  77. Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
    Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
    Genome Med, 10 (1), 92
    DOI 10.1186/s13073-018-0601-y, PubMed 30497530
  78. Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA (2018)
    Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
    Mod Pathol, 31 (11), 1694-1707
    DOI 10.1038/s41379-018-0074-y, PubMed 29946184
  79. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
    Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
    Br J Surg, 106 (4), 419-426
    DOI 10.1002/bjs.11027, PubMed 30507040
  80. Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
    Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
    Ann Surg Oncol, 25 (5), 1133-1139
    DOI 10.1245/s10434-018-6353-5, PubMed 29435684
  81. Ihle MA, Huss S, Jeske W, Hartmann W, Merkelbach-Bruse S, Schildhaus HU, Büttner R, Sihto H, Sundby Hall K, Eriksson M, Reichardt P, Joensuu H, Wardelmann E (2018)
    Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment
    PLoS One, 13 (2), e0193048
    DOI 10.1371/journal.pone.0193048, PubMed 29451912
  82. Jabeen S, Espinoza JA, Torland LA, Zucknick M, Kumar S, Haakensen VD, Lüders T, Engebraaten O, Børresen-Dale AL, Kyte JA, Gromov P, Naume B, Kristensen V, Gromova I, Tekpli X (2018)
    Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
    Oncoimmunology, 8 (2), e1537691
    DOI 10.1080/2162402X.2018.1537691, PubMed 30713794
  83. Jabeen S, Zucknick M, Nome M, Dannenfelser R, Fleischer T, Kumar S, Lüders T, von der Lippe Gythfeldt H, Troyanskaya O, Kyte JA, Børresen-Dale AL, Naume B, Tekpli X, Engebraaten O, Kristensen V (2018)
    Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab
    Oncoimmunology, 7 (11), e1457598
    DOI 10.1080/2162402X.2018.1457598, PubMed 30377556
  84. Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2018)
    Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time
    Qual Life Res, 27 (5), 1213-1215
    DOI 10.1007/s11136-017-1708-0, PubMed 29168123
  85. Jahr G, Broi MD, Holte H, Beiske K, Meling TR (2018)
    Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
    Brain Behav, 8 (3), e00928
    DOI 10.1002/brb3.928, PubMed 29541540
  86. Jahr G, Da Broi M, Holte H, Beiske K, Meling TR (2018)
    The role of surgery in intracranial PCNSL
    Neurosurg Rev, 41 (4), 1037-1044
    DOI 10.1007/s10143-018-0946-0, PubMed 29383600
  87. Jakobsen G, Engstrøm M, Fayers P, Hjermstad MJ, Kaasa S, Kloke M, Sabatowski R, Klepstad P (2018)
    Sleep quality with WHO Step III opioid use for cancer pain
    BMJ Support Palliat Care, 9 (3), 307-315
    DOI 10.1136/bmjspcare-2017-001399, PubMed 30018128
  88. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
    MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    Cancer Genomics Proteomics, 15 (6), 437-446
    DOI 10.21873/cgp.20102, PubMed 30343277
  89. Johansen S, Hauge IHR, Hogg P, England A, Lanca L, Gunn C, Sanderud A (2018)
    Are Antimony-Bismuth Aprons as Efficient as Lead Rubber Aprons in Providing Shielding against Scattered Radiation?
    J. Med. Imaging Radiat. Sci., 49 (2), 201-206
  90. Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotté F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard JY, Cervantes A (2018)
    European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
    Ann Oncol, 29 (1), 36-43
    DOI 10.1093/annonc/mdx757, PubMed 29253069
  91. Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
    Br J Cancer, 118 (10), 1322-1328
    DOI 10.1038/s41416-018-0085-y, PubMed 29695770
  92. Kiserud CE, Dahl AA, Fosså SD (2018)
    Cancer Survivorship in Adults
    Recent Results Cancer Res, 210, 123-143
    DOI 10.1007/978-3-319-64310-6_8, PubMed 28924683
  93. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV et al. (2018)
    Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
    JAMA, 319 (9), 896-905
    DOI 10.1001/jama.2018.0587, PubMed 29509865
  94. Krogstad H, Sundt-Hansen SM, Hjermstad MJ, Hågensen LÅ, Kaasa S, Loge JH, Raj SX, Steinsbekk A, Sand K (2018)
    Usability testing of EirV3-a computer-based tool for patient-reported outcome measures in cancer
    Support Care Cancer, 27 (5), 1835-1844
    DOI 10.1007/s00520-018-4435-3, PubMed 30173402
  95. Kvæl LAH, Debesay J, Langaas A, Bye A, Bergland A (2018)
    A Concept Analysis of Patient Participation in Intermediate Care
    Patient Educ Couns, 101 (8), 1337-1350
    DOI 10.1016/j.pec.2018.03.005, PubMed 29551564
  96. Kaasa S, Loge JH (2018)
    Early integration of palliative care-new evidence and old questions
    Lancet Oncol, 19 (3), 280-281
    DOI 10.1016/S1470-2045(18)30061-5, PubMed 29402702
  97. Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gómez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R et al. (2018)
    Integration of oncology and palliative care: a Lancet Oncology Commission
    Lancet Oncol, 19 (11), e588-e653
    DOI 10.1016/S1470-2045(18)30415-7, PubMed 30344075
  98. Lampen MH, Uchtenhagen H, Blom K, Varnaitė R, Pakalniene J, Dailidyte L, Wälchli S, Lindquist L, Mickiene A, Michaëlsson J, Schumacher TN, Ljunggren HG, Sandberg JK, Achour A, Gredmark-Russ S (2018)
    Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection
    Immunohorizons, 2 (6), 172-184
    DOI 10.4049/immunohorizons.1800029, PubMed 31022685
  99. Landmark T, Dale O, Romundstad P, Woodhouse A, Kaasa S, Borchgrevink PC (2018)
    Development and course of chronic pain over 4 years in the general population: The HUNT pain study
    Eur J Pain, 22 (9), 1606-1616
    DOI 10.1002/ejp.1243, PubMed 29754398
  100. Langberg MK, Berglund-Nord C, Cohn-Cedermark G, Haugnes HS, Tandstad T, Langberg CW (2018)
    Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA
    Acta Oncol, 57 (10), 1401-1406
    DOI 10.1080/0284186X.2018.1479072, PubMed 29869895
  101. Latysheva A, Eeg Emblem K, Server A, Brandal P, Meling TR, Pahnke J, Hald JK (2018)
    Survival Associations Using Perfusion and Diffusion Magnetic Resonance Imaging in Patients With Histologic and Genetic Defined Diffuse Glioma World Health Organization Grades II and III
    J Comput Assist Tomogr, 42 (5), 807-815
    DOI 10.1097/RCT.0000000000000742, PubMed 29901512
  102. Line PD, Hagness M, Dueland S (2018)
    The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
    Can J Gastroenterol Hepatol, 2018, 8547940
    DOI 10.1155/2018/8547940, PubMed 29623266
  103. Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, Stensvold A, Reitan JB, Akslen LA, Thune I (2018)
    Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
    BMC Cancer, 18 (1), 654
    DOI 10.1186/s12885-018-4568-2, PubMed 29902993
  104. Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K (2018)
    Pazopanib in relapsed osteosarcoma patients: report on 15 cases
    Acta Oncol, 58 (1), 124-128
    DOI 10.1080/0284186X.2018.1503714, PubMed 30207179
  105. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
    Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Acta Neurochir (Wien), 160 (6), 1207-1214
    DOI 10.1007/s00701-018-3550-8, PubMed 29680921
  106. Lunde P, Nilsson BB, Bergland A, Kværner KJ, Bye A (2018)
    The Effectiveness of Smartphone Apps for Lifestyle Improvement in Noncommunicable Diseases: Systematic Review and Meta-Analyses
    J Med Internet Res, 20 (5), e162
    DOI 10.2196/jmir.9751, PubMed 29728346
  107. Løhre ET, Hjermstad MJ, Brunelli C, Knudsen AK, Kaasa S, Klepstad P (2018)
    Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
    Pain Ther, 7 (2), 193-203
    DOI 10.1007/s40122-018-0107-8, PubMed 30415462
  108. Madeira T, Peixoto-Plácido C, Sousa-Santos N, Santos O, Alarcão V, Goulão B, Mendonça N, Nicola PJ, Yngve A, Bye A, Bergland A, Amaral TF, Lopes C, Gorjão Clara J (2018)
    Malnutrition among older adults living in Portuguese nursing homes: the PEN-3S study
    Public Health Nutr, 22 (3), 486-497
    DOI 10.1017/S1368980018002318, PubMed 30319081
  109. Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
    Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
    Br J Cancer, 119 (9), 1144-1154
    DOI 10.1038/s41416-018-0211-x, PubMed 30401977
  110. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
  111. Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW et al. (2018)
    Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
    Am J Hum Genet, 104 (1), 21-34
    DOI 10.1016/j.ajhg.2018.11.002, PubMed 30554720
  112. Meling TR, Latysheva A, Da Broi M, Jahr G, Holte H, Beiske K, Emblem KE (2018)
    Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
    Neuroradiology, 60 (7), 703-713
    DOI 10.1007/s00234-018-2038-9, PubMed 29804159
  113. Moberg IO, Schou Bredal I, Schneider MR, Tønseth KA, Schlichting E (2018)
    Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations
    J Plast Surg Hand Surg, 52 (4), 234-239
    DOI 10.1080/2000656X.2018.1470093, PubMed 29741462
  114. Mohammed Ali A, Hogg P, Johansen S, England A (2018)
    Construction and validation of a low cost paediatric pelvis phantom
    Eur J Radiol, 108, 84-91
    DOI 10.1016/j.ejrad.2018.09.015, PubMed 30396676
  115. Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, Holte H, Savage KJ, Glinsmann-Gibson BJ, Gascoyne RD, Staudt LM, Jaffe ES, Connors JM, Scott DW, Steidl C, Rimsza LM (2018)
    Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens
    Blood, 132 (22), 2401-2405
    DOI 10.1182/blood-2018-05-851154, PubMed 30257882
  116. Najjari Jamal D, Pötter R, Haie-Meder C, Lindegaard JC, Juergenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Tanderup K, Kirchheiner K, EMBRACE collaborative group (2018)
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
    Radiother Oncol, 127 (3), 449-455
    DOI 10.1016/j.radonc.2018.03.026, PubMed 29631933
  117. Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA (2018)
    Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor
    Mol Cancer Ther, 17 (11), 2473-2480
    DOI 10.1158/1535-7163.MCT-18-0174, PubMed 30097488
  118. Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L (2018)
    BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
    ESMO Open, 3 (3), e000328
    DOI 10.1136/esmoopen-2018-000328, PubMed 29682331
  119. Novello S, Mazières J, Oh IJ, de Castro J, Migliorino MR, Helland Å, Dziadziuszko R, Griesinger F, Kotb A, Zeaiter A, Cardona A, Balas B, Johannsdottir HK, Das-Gupta A, Wolf J (2018)
    Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
    Ann Oncol, 29 (6), 1409-1416
    DOI 10.1093/annonc/mdy121, PubMed 29668860
  120. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
    Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
    Cancer Immunol Res, 6 (4), 467-480
    DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477
  121. Oltedal S, Kørner H, Aasprong OG, Hussain I, Tjensvoll K, Smaaland R, Søreide JA, Søreide K, Lothe RA, Heikkilä R, Gilje B, Nordgård O (2018)
    The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
    Transl Oncol, 11 (2), 436-443
    DOI 10.1016/j.tranon.2018.01.015, PubMed 29475140
  122. Oltedal S, Skaland I, Maple-Grødem J, Tjensvoll K, Janssen EAM, Gilje B, Smaaland R, Heikkilä R, Nordgård O (2018)
    Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
    BMC Gastroenterol, 18 (1), 26
    DOI 10.1186/s12876-018-0752-8, PubMed 29415677
  123. Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B (2018)
    Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma
    Virchows Arch, 473 (4), 463-470
    DOI 10.1007/s00428-018-2418-x, PubMed 30032361
  124. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
    Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
    Eur Thyroid J, 8 (1), 31-40
    DOI 10.1159/000493977, PubMed 30800639
  125. Ottestad I, Ulven SM, Øyri LKL, Sandvei KS, Gjevestad GO, Bye A, Sheikh NA, Biong AS, Andersen LF, Holven KB (2018)
    Reduced plasma concentration of branched-chain amino acids in sarcopenic older subjects: a cross-sectional study
    Br J Nutr, 120 (4), 445-453
    DOI 10.1017/S0007114518001307, PubMed 29909813
  126. Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C (2018)
    DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
    Radiother Oncol, 127 (1), 12-19
    DOI 10.1016/j.radonc.2018.02.018, PubMed 29523409
  127. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
    Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
    Cancer Genomics Proteomics, 15 (5), 379-385
    DOI 10.21873/cgp.20096, PubMed 30194078
  128. Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Dirven L, Fayers P, Gamper EM, Giesinger JM, Habets EJJ, Hammerlid E, Helbostad J, Hjermstad MJ, Holzner B, Johnson C, Kemmler G, King MT, Kaasa S, Loge JH, Reijneveld JC, Singer S, Taphoorn MJB, Thamsborg LH, Tomaszewski KA et al. (2018)
    The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire
    Eur J Cancer, 100, 8-16
    DOI 10.1016/j.ejca.2018.04.016, PubMed 29936066
  129. Prasmickaite L, Tenstad EM, Pettersen S, Jabeen S, Egeland EV, Nord S, Pandya A, Haugen MH, Kristensen VN, Børresen-Dale AL, Oslo Breast Cancer Research Consortium (OSBREAC), Engebråten O, Maelandsmo GM (2018)
    Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4
    Mol Oncol, 12 (9), 1540-1558
    DOI 10.1002/1878-0261.12319, PubMed 29741811
  130. Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I et al. (2018)
    The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
    Clin Transl Radiat Oncol, 9, 48-60
    DOI 10.1016/j.ctro.2018.01.001, PubMed 29594251
  131. Rauert-Wunderlich H, Mottok A, Scott DW, Rimsza LM, Ott G, Klapper W, Unterhalt M, Kluin-Nelemans HC, Hermine O, Hartmann S, Thorns C, Rymkiewicz G, Holte H, Dreyling M, Hoster E, Rosenwald A (2018)
    Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
    Br J Haematol, 184 (4), 616-624
    DOI 10.1111/bjh.15519, PubMed 30095158
  132. Rogg L (2018)
    NO MAN'S LAND For those who did not die, who are no longer sick, nor are they healthy
    Tidsskr. Nor. Laegeforen., 138 (5), 483
  133. Ryalen PC, Stensrud MJ, Fosså S, Røysland K (2018)
    Causal inference in continuous time: an example on prostate cancer therapy
    Biostatistics (in press)
    DOI 10.1093/biostatistics/kxy036, PubMed 30124773
  134. Rye IH, Trinh A, Saetersdal AB, Nebdal D, Lingjaerde OC, Almendro V, Polyak K, Børresen-Dale AL, Helland Å, Markowetz F, Russnes HG (2018)
    Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors
    Mol Oncol, 12 (11), 1838-1855
    DOI 10.1002/1878-0261.12375, PubMed 30133130
  135. Røen I, Stifoss-Hanssen H, Grande G, Brenne AT, Kaasa S, Sand K, Knudsen AK (2018)
    Resilience for family carers of advanced cancer patients-how can health care providers contribute? A qualitative interview study with carers
    Palliat Med, 32 (8), 1410-1418
    DOI 10.1177/0269216318777656, PubMed 29852808
  136. Sá Dos Reis C, Pires Jorge JA, York H, Flaction L, Johansen S, Mæhle S (2018)
    A comparative study about motivations, expectations and future plans for professional development in four European radiography programs
    Radiography (Lond), 24 (4), e91-e97
    DOI 10.1016/j.radi.2018.05.007, PubMed 30292519
  137. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM et al. (2018)
    Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
    Int J Radiat Oncol Biol Phys, 101 (4), 883-888
    DOI 10.1016/j.ijrobp.2018.03.060, PubMed 29976500
  138. Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT, JULIET Investigators (2018)
    Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    N Engl J Med, 380 (1), 45-56
    DOI 10.1056/NEJMoa1804980, PubMed 30501490
  139. Schöffski P, Wozniak A, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Gelderblom H, Italiano A, Lindner LH, Hennig I, Strauss S, Zakotnik B, Anthoney A, Albiges L, Blay JY, Reichardt P, Sufliarsky J, van der Graaf WTA, Debiec-Rychter M, Sciot R, Van Cann T, Marréaud S, Raveloarivahy T, Collette S et al. (2018)
    Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'
    Ann Oncol, 29 (3), 758-765
    DOI 10.1093/annonc/mdx774, PubMed 29216400
  140. Schöffski P, Wozniak A, Leahy MG, Aamdal S, Rutkowski P, Bauer S, Richter S, Grünwald V, Debiec-Rychter M, Sciot R, Geoerger B, Marréaud S, Collette S, Nzokirantevye A, Strauss SJ (2018)
    The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'
    Eur J Cancer, 94, 156-167
    DOI 10.1016/j.ejca.2018.02.011, PubMed 29567632
  141. Seip K, Jørgensen K, Haselager MV, Albrecht M, Haugen MH, Egeland EV, Lucarelli P, Engebraaten O, Sauter T, Mælandsmo GM, Prasmickaite L (2018)
    Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment
    Cancer Lett, 439, 1-13
    DOI 10.1016/j.canlet.2018.09.023, PubMed 30240588
  142. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
    Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
    Acta Oncol, 57 (9), 1240-1249
    DOI 10.1080/0284186X.2018.1465588, PubMed 29698060
  143. Serban M, Kirisits C, Pötter R, de Leeuw A, Nkiwane K, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Oinam A, Bownes P, Oosterveld B, De Brabandere M, Koedooder K, Marthinsen ABL, Lindegaard J, Tanderup K, EMBRACE Collaborative Group (2018)
    Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy
    Radiother Oncol, 129 (3), 567-574
    DOI 10.1016/j.radonc.2018.09.002, PubMed 30243671
  144. Skah S, Richartz N, Duthil E, Gilljam KM, Bindesbøll C, Naderi EH, Eriksen AB, Ruud E, Dirdal MM, Simonsen A, Blomhoff HK (2018)
    cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53
    Oncotarget, 9 (54), 30434-30449
    DOI 10.18632/oncotarget.25758, PubMed 30100998
  145. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
    Dose painting for re-irradiation of head and neck cancer
    Acta Oncol, 57 (12), 1693-1699
    DOI 10.1080/0284186X.2018.1512753, PubMed 30280623
  146. Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO (2018)
    Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
    Clin Nutr ESPEN, 28, 59-66
    DOI 10.1016/j.clnesp.2018.08.002, PubMed 30390894
  147. Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA (2018)
    CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer
    Ann Oncol, 29 (5), 1227-1234
    DOI 10.1093/annonc/mdy085, PubMed 29518181
  148. Smedman TM, Line PD, Guren TK, Dueland S (2018)
    Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
    Acta Oncol, 57 (10), 1414-1418
    DOI 10.1080/0284186X.2018.1479069, PubMed 29912605
  149. Smeland KB, Loge JH, Aass HCD, Aspelin T, Bersvendsen H, Bolstad N, Fagerli UM, Falk RS, Fluge Ø, Fosså A, Holte H, Lund MB, Murbræch K, Reinertsen KV, Stenehjem JS, Kiserud CE (2018)
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
    Bone Marrow Transplant, 54 (4), 607-610
    DOI 10.1038/s41409-018-0342-y, PubMed 30262906
  150. Smet S, Pötter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K, EMBRACE Collaborative Group (2018)
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
    Radiother Oncol, 127 (3), 440-448
    DOI 10.1016/j.radonc.2018.03.009, PubMed 29627137
  151. Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
    Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
    Acta Obstet Gynecol Scand, 98 (2), 240-249
    DOI 10.1111/aogs.13477, PubMed 30289161
  152. Solheim TS, Laird BJA, Balstad TR, Bye A, Stene G, Baracos V, Strasser F, Griffiths G, Maddocks M, Fallon M, Kaasa S, Fearon K (2018)
    Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
    BMJ Support Palliat Care, 8 (3), 258-265
    DOI 10.1136/bmjspcare-2017-001440, PubMed 29440149
  153. Steinberg MT, Olsen JA, Eriksen M, Neset A, Norseng PA, Kramer-Johansen J, Hardig BM, Wik L (2018)
    Haemodynamic outcomes during piston-based mechanical CPR with or without active decompression in a porcine model of cardiac arrest
    Scand J Trauma Resusc Emerg Med, 26 (1), 31
    DOI 10.1186/s13049-018-0496-z, PubMed 29690910
  154. Stokke C, Blakkisrud J, Løndalen A, Dahle J, Martinsen ACT, Holte H, Kolstad A (2018)
    Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients
    Eur J Nucl Med Mol Imaging, 45 (7), 1233-1241
    DOI 10.1007/s00259-018-3964-9, PubMed 29470615
  155. Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O (2018)
    SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
    Scand J Urol, 52 (5-6), 313-320
    DOI 10.1080/21681805.2018.1520295, PubMed 30585526
  156. Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M (2018)
    Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
    Eur J Cancer, 99, 78-85
    DOI 10.1016/j.ejca.2018.05.011, PubMed 29929092
  157. Sweegers MG, Altenburg TM, Brug J, May AM, van Vulpen JK, Aaronson NK, Arbane G, Bohus M, Courneya KS, Daley AJ, Galvao DA, Garrod R, Griffith KA, Van Harten WH, Hayes SC, Herrero-Román F, Kersten MJ, Lucia A, McConnachie A, van Mechelen W, Mutrie N, Newton RU, Nollet F, Potthoff K, Schmidt ME et al. (2018)
    Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data
    Br J Sports Med, 53 (13), 812
    DOI 10.1136/bjsports-2018-099191, PubMed 30181323
  158. Thomsen M, Skovlund E, Sorbye H, Bolstad N, Nustad KJ, Glimelius B, Pfeiffer P, Kure EH, Johansen JS, Tveit KM, Christoffersen T, Guren TK (2018)
    Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
    Br J Cancer, 118 (12), 1609-1616
    DOI 10.1038/s41416-018-0115-9, PubMed 29872151
  159. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637
  160. Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
    Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
    Acta Radiol, 60 (8), 1028-1038
    DOI 10.1177/0284185118810977, PubMed 30379559
  161. Tøndel H, Lund JÅ, Lydersen S, Wanderås AD, Aksnessæther B, Jensen CA, Kaasa S, Solberg A (2018)
    Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial
    Radiother Oncol, 126 (2), 229-235
    DOI 10.1016/j.radonc.2017.10.029, PubMed 29398152
  162. Tøndel H, Lund JÅ, Lydersen S, Wanderås AD, Aksnessæther BY, Jensen CA, Kaasa S, Solberg A (2018)
    Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial
    Clin Transl Radiat Oncol, 13, 50-56
    DOI 10.1016/j.ctro.2018.09.006, PubMed 30364704
  163. Vade C, Næss S (2018)
    A Scandinavian Point of View: Caring for Patients With Sarcoma Across Boundaries
    Clin J Oncol Nurs, 22 (3), 357-359
    DOI 10.1188/18.CJON.357-359, PubMed 29781457
  164. Valan CD, Slagsvold JE, Halvorsen TO, Herje M, Bremnes RM, Brunsvig PF, Brustugun OT, Fløtten Ø, Levin N, Sundstrøm SH, Grønberg BH (2018)
    Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement
    Anticancer Res, 38 (2), 871-876
    DOI 10.21873/anticanres.12296, PubMed 29374714
  165. van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P et al. (2018)
    Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
    JMIR Res Protoc, 7 (9), e10824
    DOI 10.2196/10824, PubMed 30215599
  166. van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, van den Berg M, Berger C, Calaminus G, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kremer L, Kruseova J, Modan-Moses D, Ranft A, Spix C, Kaatsch P, Laven JSE, van Dulmen-den Broeder E, Uitterlinden AG et al. (2018)
    Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
    BMC Cancer, 18 (1), 930
    DOI 10.1186/s12885-018-4834-3, PubMed 30257669
  167. van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS et al. (2018)
    International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
    Blood, 132 (20), 2115-2124
    DOI 10.1182/blood-2018-07-862334, PubMed 30181172
  168. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    J Am Acad Dermatol, 79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
  169. Vermeer NCA, Claassen YHM, Derks MGM, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Portielje JEA, Liefers GJ, Peeters KCMJ, van de Velde CJH, Bastiaannet E (2018)
    Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison
    Oncologist, 23 (8), 982-990
    DOI 10.1634/theoncologist.2017-0551, PubMed 29567826
  170. Vistad I, Cvancarova M, Lindviksmoen Astrup G, Rustøen T, Liavaag AH (2018)
    Symptom Experience and Self-rated Physical Functioning in Patients With Ovarian Cancer Receiving Chemotherapy: A Longitudinal Study
    Int J Gynecol Cancer, 28 (6), 1167-1175
    DOI 10.1097/IGC.0000000000001287, PubMed 29781824
  171. Vodák D, Lorenz S, Nakken S, Aasheim LB, Holte H, Bai B, Myklebost O, Meza-Zepeda LA, Hovig E (2018)
    Sample-Index Misassignment Impacts Tumour Exome Sequencing
    Sci Rep, 8 (1), 5307
    DOI 10.1038/s41598-018-23563-4, PubMed 29593270
  172. Våtsveen TK, Myhre MR, Steen CB, Wälchli S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018)
    Artesunate shows potent anti-tumor activity in B-cell lymphoma
    J Hematol Oncol, 11 (1), 23
    DOI 10.1186/s13045-018-0561-0, PubMed 29458389
  173. Wedde TB, Småstuen MC, Brabrand S, Fosså SD, Kaasa S, Tafjord G, Russnes KM, Hellebust TP, Lilleby W (2018)
    Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort
    Radiother Oncol, 132, 211-217
    DOI 10.1016/j.radonc.2018.10.013, PubMed 30389241
  174. Weller D, Menon U, Zalounina Falborg A, Jensen H, Barisic A, Knudsen AK, Bergin RJ, Brewster DH, Cairnduff V, Gavin AT, Grunfeld E, Harland E, Lambe M, Law RJ, Lin Y, Malmberg M, Turner D, Neal RD, White V, Harrison S, Reguilon I, ICBP Module 4 Working Group, Vedsted P (2018)
    Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP)
    BMJ Open, 8 (11), e023870
    DOI 10.1136/bmjopen-2018-023870, PubMed 30482749
  175. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH (2018)
    Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Transl Oncol, 11 (2), 259-267
    DOI 10.1016/j.tranon.2017.12.011, PubMed 29413758
  176. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH (2018)
    Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice
    J Labelled Comp Radiopharm, 61 (6), 472-486
    DOI 10.1002/jlcr.3610, PubMed 29380410
  177. Yachnin J, Gilje B, Thon K, Johansson H, Brandberg Y, Panaretakis T, Ullén A (2018)
    Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
    Eur J Cancer, 97, 33-40
    DOI 10.1016/j.ejca.2018.03.007, PubMed 29685343
  178. Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2018)
    Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors
    J Natl Compr Canc Netw, 16 (3), 257-265
    DOI 10.6004/jnccn.2017.7046, PubMed 29523664
  179. Zaikova O, Berner K (2018)
    Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
    J Surg Oncol, 118 (1), 248
    DOI 10.1002/jso.25135, PubMed 30208204
  180. Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
    Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
    World J Urol, 37 (8), 1571-1580
    DOI 10.1007/s00345-018-2570-6, PubMed 30483947
  181. Åsli LM, Myklebust TÅ, Kvaløy SO, Jetne V, Møller B, Levernes SG, Johannesen TB (2018)
    Factors influencing access to palliative radiotherapy: a Norwegian population-based study
    Acta Oncol, 57 (9), 1250-1258
    DOI 10.1080/0284186X.2018.1468087, PubMed 29706109

Publications 2017

  1. Abravan A, Eide HA, Knudtsen IS, Løndalen AM, Helland Å, Malinen E (2017)
    Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
    Clin Transl Radiat Oncol, 4, 57-63
    DOI 10.1016/j.ctro.2017.04.002, PubMed 29594209
  2. Abravan A, Knudtsen IS, Eide HA, Løndalen AM, Helland Å, van Luijk P, Malinen E (2017)
    A new method to assess pulmonary changes using 18F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy
    Acta Oncol, 56 (11), 1597-1603
    DOI 10.1080/0284186X.2017.1349336, PubMed 28849707
  3. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
    Improved treatment decisions in patients with esophageal cancer
    Acta Oncol, 56 (10), 1286-1294
    DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
  4. Astrup GL, Hofsø K, Bjordal K, Guren MG, Vistad I, Cooper B, Miaskowski C, Rustøen T (2017)
    Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
    Acta Oncol, 56 (3), 462-470
    DOI 10.1080/0284186X.2016.1273546, PubMed 28077018
  5. Astrup GL, Rustøen T, Hofsø K, Gran JM, Bjordal K (2017)
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy
    Head Neck, 39 (10), 2114-2126
    DOI 10.1002/hed.24875, PubMed 28766791
  6. Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
    Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
    Breast Cancer Res, 19 (1), 44
    DOI 10.1186/s13058-017-0812-y, PubMed 28356166
  7. Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
    Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
    BMC Urol, 17 (1), 111
    DOI 10.1186/s12894-017-0302-7, PubMed 29197360
  8. Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
    Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
    Acta Oncol, 56 (6), 813-818
    DOI 10.1080/0284186X.2017.1287951, PubMed 28464745
  9. Barzenje DA, Kolstad A, Ghanima W, Holte H (2017)
    Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years
    Hematol Oncol, 36 (1), 217-223
    DOI 10.1002/hon.2415, PubMed 28393375
  10. Belfrage A, Grotmol KS, Lien L, Moum T, Wiese RV, Tyssen R (2017)
    Medical school predictors of later perceived mastery of clinical work among Norwegian doctors: a cohort study with 10-year and 20-year follow-up
    BMJ Open, 7 (9), e014462
    DOI 10.1136/bmjopen-2016-014462, PubMed 28947437
  11. Bjørklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Alnæs GIG, Toppmeyer D, Riis M, Naume B, Børresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G (2017)
    Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
    Sci Rep, 7 (1), 5568
    DOI 10.1038/s41598-017-05537-0, PubMed 28717182
  12. Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C (2017)
    Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    J Nucl Med, 59 (4), 704-710
    DOI 10.2967/jnumed.117.195347, PubMed 28848035
  13. Bollum LK, Huse K, Oksvold MP, Bai B, Hilden VI, Forfang L, Yoon SO, Wälchli S, Smeland EB, Myklebust JH (2017)
    BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5
    PLoS One, 12 (5), e0177188
    DOI 10.1371/journal.pone.0177188, PubMed 28489883
  14. Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS (2017)
    Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
    Acta Oncol, 56 (3), 479-483
    DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
  15. Broughton MN, Westgaard A, Paus E, Øijordsbakken M, Henanger KJ, Naume B, Bjøro T (2017)
    Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Tumour Biol, 39 (6), 1010428317707436
    DOI 10.1177/1010428317707436, PubMed 28653892
  16. Bryhn B, Tveit KM (2017)
    National intestinal screening will reduce the occurrence and mortality of intestinal cancer
    Tidsskr. Nor. Laegeforen., 137 (21), 1664
  17. Bye A, Sjøblom B, Wentzel-Larsen T, Grønberg BH, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Jordhøy M (2017)
    Muscle mass and association to quality of life in non-small cell lung cancer patients
    J Cachexia Sarcopenia Muscle, 8 (5), 759-767
    DOI 10.1002/jcsm.12206, PubMed 28493418
  18. Chen H, Ewing CM, Zheng S, Grindedaal EM, Cooney KA, Wiley K, Djurovic S, Andreassen OA, Axcrona K, Mills IG, Xu J, Maehle L, Fosså SD, Isaacs WB (2017)
    Genetic factors influencing prostate cancer risk in Norwegian men
    Prostate, 78 (3), 186-192
    DOI 10.1002/pros.23453, PubMed 29181843
  19. Dahl AA (2017)
    [Racing thoughts - a psychiatric term without meaning?]
    Tidsskr Nor Laegeforen, 137 (16)
    DOI 10.4045/tidsskr.17.0161, PubMed 28871751
  20. Dahl AA (2017)
    Racing thoughts- a psychiatric term without meaning?
    Tidsskr. Nor. Laegeforen., 137 (16), 1226
  21. Dannenfelser R, Nome M, Tahiri A, Ursini-Siegel J, Vollan HKM, Haakensen VD, Helland Å, Naume B, Caldas C, Børresen-Dale AL, Kristensen VN, Troyanskaya OG (2017)
    Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
    Oncotarget, 8 (34), 57121-57133
    DOI 10.18632/oncotarget.19078, PubMed 28915659
  22. Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB, Platinum Study Group (2017)
    Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
    Clin Cancer Res, 23 (19), 5757-5768
    DOI 10.1158/1078-0432.CCR-16-3224, PubMed 28611204
  23. Dueland S, Guren TK, Boberg KM, Reims HM, Grzyb K, Aamdal S, Julsrud L, Line PD (2017)
    Acute liver graft rejection after ipilimumab therapy
    Ann Oncol, 28 (10), 2619-2620
    DOI 10.1093/annonc/mdx281, PubMed 28961840
  24. Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M (2017)
    Interactions between the tumor and the blood systemic response of breast cancer patients
    PLoS Comput Biol, 13 (9), e1005680
    DOI 10.1371/journal.pcbi.1005680, PubMed 28957325
  25. Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T, Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM (2017)
    Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
    Breast Cancer Res Treat, 162 (1), 127-137
    DOI 10.1007/s10549-016-4096-1, PubMed 28058579
  26. Eide N, Faye RS, Høifødt HK, Sandvik L, Qvale GA, Faber R, Jebsen P, Kvalheim G, Fodstad Ø (2017)
    The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
    Pathol Oncol Res, 25 (1), 255-262
    DOI 10.1007/s12253-017-0355-7, PubMed 29098521
  27. Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, Räty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Grønbæk K (2017)
    TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
    Blood, 130 (17), 1903-1910
    DOI 10.1182/blood-2017-04-779736, PubMed 28819011
  28. Euceda LR, Haukaas TH, Giskeodegard GF, Vettukattil R, Engel J, Silwal-Pandit L, Lundgren S, Borgen E, Garred O, Postma G, Buydens LMC, Borresen-Dale AL, Engebraaten O, Bathen TF (2017)
    Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy
    Metabolomics, 13 (4), 37
  29. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS et al. (2017)
    International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease
    Blood, 129 (12), 1646-1657
    DOI 10.1182/blood-2016-10-746933, PubMed 28087540
  30. Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim SW, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim DW, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB (2017)
    Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer
    J Thorac Oncol, 13 (4), 576-584
    DOI 10.1016/j.jtho.2017.11.131, PubMed 29247830
  31. Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN (2017)
    DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
    Oncotarget, 8 (1), 1074-1082
    DOI 10.18632/oncotarget.13718, PubMed 27911866
  32. Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Oslo Breast Cancer Research Consortium (OSBREAC), Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017)
    DNA methylation at enhancers identifies distinct breast cancer lineages
    Nat Commun, 8 (1), 1379
    DOI 10.1038/s41467-017-00510-x, PubMed 29123100
  33. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
    Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
    Ann Surg Oncol, 24 (7), 1916-1922
    DOI 10.1245/s10434-017-5814-6, PubMed 28224367
  34. Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H (2017)
    Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas
    Eur J Surg Oncol, 43 (9), 1682-1689
    DOI 10.1016/j.ejso.2017.04.010, PubMed 28522174
  35. Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM et al. (2017)
    Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
    Radiat Res, 187 (2), 186-195
    DOI 10.1667/RR14453.1, PubMed 28118119
  36. Gingras I, Holmes E, De Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart MJ, Azim HA (2017)
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial
    J Natl Cancer Inst, 109 (8)
    DOI 10.1093/jnci/djw331, PubMed 28376188
  37. Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N, Jamieson L, Vyas P, Anderson K, Segerstolpe Å, Qian H, Olsson-Strömberg U, Mustjoki S, Sandberg R, Jacobsen SEW, Mead AJ (2017)
    Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
    Nat Med, 23 (6), 692-702
    DOI 10.1038/nm.4336, PubMed 28504724
  38. Gjerset GM, Loge JH, Kiserud CE, Fosså SD, Gudbergsson SB, Oldervoll LM, Wisløff T, Thorsen L (2017)
    Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue
    Acta Oncol, 56 (2), 245-253
    DOI 10.1080/0284186X.2016.1266091, PubMed 28075207
  39. Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E (2017)
    Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
    BMC Cancer, 17 (1), 438
    DOI 10.1186/s12885-017-3422-2, PubMed 28637432
  40. Grotmol KS, Lie HC, Hjermstad MJ, Aass N, Currow D, Kaasa S, Moum TÅ, Pigni A, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2017)
    Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer
    J Pain Symptom Manage, 54 (6), 889-897
    DOI 10.1016/j.jpainsymman.2017.04.010, PubMed 28803091
  41. Grov EK, Fosså SD, Dahl AA (2017)
    A controlled study of the influence of comorbidity on activities of daily living in elderly cancer survivors (the HUNT-3 survey)
    J Geriatr Oncol, 8 (5), 328-335
    DOI 10.1016/j.jgo.2017.05.007, PubMed 28629695
  42. Grut H, Dueland S, Line PD, Revheim ME (2017)
    The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
    Eur J Nucl Med Mol Imaging, 45 (2), 218-225
    DOI 10.1007/s00259-017-3843-9, PubMed 29026950
  43. Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
    Br J Surg, 105 (3), 295-301
    DOI 10.1002/bjs.10651, PubMed 29168565
  44. Gunnarsdottir S, Sigurdardottir V, Kloke M, Radbruch L, Sabatowski R, Kaasa S, Klepstad P (2017)
    A multicenter study of attitudinal barriers to cancer pain management
    Support Care Cancer, 25 (11), 3595-3602
    DOI 10.1007/s00520-017-3791-8, PubMed 28653107
  45. Guren TK, Thomsen M, Kure EH, Sorbye H, Glimelius B, Pfeiffer P, Österlund P, Sigurdsson F, Lothe IMB, Dalsgaard AM, Skovlund E, Christoffersen T, Tveit KM (2017)
    Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
    Br J Cancer, 116 (10), 1271-1278
    DOI 10.1038/bjc.2017.93, PubMed 28399112
  46. Halvorsen AR, Kristensen G, Embleton A, Adusei C, Barretina-Ginesta MP, Beale P, Helland Å (2017)
    Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients
    Dis Markers, 2017, 3098542
    DOI 10.1155/2017/3098542, PubMed 28293063
  47. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
    Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
    World J Surg Oncol, 15 (1), 118
    DOI 10.1186/s12957-017-1184-6, PubMed 28673296
  48. Heikkilä R, Kaasa S (2017)
    Chemotherapy in end-of-life care
    Ann Oncol, 28 (4), 684-685
    DOI 10.1093/annonc/mdx039, PubMed 28327919
  49. Helland T, Henne N, Bifulco E, Naume B, Borgen E, Kristensen VN, Kvaløy JT, Lash TL, Alnæs GIG, van Schaik RH, Janssen EAM, Hustad S, Lien EA, Mellgren G, Søiland H (2017)
    Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
    Breast Cancer Res, 19 (1), 125
    DOI 10.1186/s13058-017-0916-4, PubMed 29183390
  50. Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA (2017)
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    Int J Cancer, 141 (1), 184-190
    DOI 10.1002/ijc.30726, PubMed 28387924
  51. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2017)
    Post-thoracotomy pain syndrome and sensory disturbances following thoracotomy at 6- and 12-month follow-ups
    J Pain Res, 10, 663-668
    DOI 10.2147/JPR.S126639, PubMed 28356766
  52. Holm HV, Dahl AA, Klepp OH, Fosså SD (2017)
    Modern treatment of metastatic prostate cancer
    Tidsskr Nor Laegeforen, 137 (11), 803-805
    DOI 10.4045/tidsskr.16.0265, PubMed 28597635
  53. Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
    Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
    Acta Oncol, 56 (10), 1317-1323
    DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
  54. Hui D, Mori M, Meng YC, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E (2017)
    Automatic referral to standardize palliative care access: an international Delphi survey
    Support Care Cancer, 26 (1), 175-180
    DOI 10.1007/s00520-017-3830-5, PubMed 28726065
  55. Inderberg EM, Mensali N, Oksvold MP, Fallang LE, Fåne A, Skorstad G, Stenvik GE, Progida C, Bakke O, Kvalheim G, Myklebust JH, Wälchli S (2017)
    Human c-SRC kinase (CSK) overexpression makes T cells dummy
    Cancer Immunol Immunother, 67 (4), 525-536
    DOI 10.1007/s00262-017-2105-9, PubMed 29248956
  56. Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G (2017)
    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
    Oncoimmunology, 6 (4), e1302631
    DOI 10.1080/2162402X.2017.1302631, PubMed 28507809
  57. Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
    Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
    Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
    DOI 10.1007/s00405-017-4764-8, PubMed 29019001
  58. Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2017)
    Norwegian reference values for the Short-Form Health Survey 36: development over time
    Qual Life Res, 27 (5), 1201-1212
    DOI 10.1007/s11136-017-1684-4, PubMed 28808829
  59. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN et al. (2017)
    PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
    Oncotarget, 8 (61), 102769-102782
    DOI 10.18632/oncotarget.21800, PubMed 29262523
  60. Joensuu H, Wardelmann E, Sihto H, Eriksson M, Sundby Hall K, Reichardt A, Hartmann JT, Pink D, Cameron S, Hohenberger P, Al-Batran SE, Schlemmer M, Bauer S, Nilsson B, Kallio R, Junnila J, Vehtari A, Reichardt P (2017)
    Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial
    JAMA Oncol, 3 (5), 602-609
    DOI 10.1001/jamaoncol.2016.5751, PubMed 28334365
  61. Johannsdottir IM, Loge JH, Kiserud CE, Karlstad Ø, Skurtveit S (2017)
    Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthood-A population-based study
    Pediatr Blood Cancer, 65 (2)
    DOI 10.1002/pbc.26860, PubMed 29077266
  62. Johannsdottir IMR, Hamre H, Fosså SD, Loge JH, Drolsum L, Lund MB, Nordsletten L, Kiserud C (2017)
    Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors
    J Adolesc Young Adult Oncol, 6 (3), 470-476
    DOI 10.1089/jayao.2017.0018, PubMed 28837384
  63. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, Evensen JF (2017)
    Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
    Radiat Oncol, 12 (1), 87
    DOI 10.1186/s13014-017-0829-5, PubMed 28545588
  64. Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2017)
    T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling
    Clin Cancer Res, 24 (4), 870-881
    DOI 10.1158/1078-0432.CCR-17-2337, PubMed 29217528
  65. Juvet LK, Thune I, Elvsaas IKØ, Fors EA, Lundgren S, Bertheussen G, Leivseth G, Oldervoll LM (2017)
    The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysis
    Breast, 33, 166-177
    DOI 10.1016/j.breast.2017.04.003, PubMed 28415013
  66. Kirkhus L, Šaltytė Benth J, Rostoft S, Grønberg BH, Hjermstad MJ, Selbæk G, Wyller TB, Harneshaug M, Jordhøy MS (2017)
    Geriatric assessment is superior to oncologists' clinical judgement in identifying frailty
    Br J Cancer, 117 (4), 470-477
    DOI 10.1038/bjc.2017.202, PubMed 28664916
  67. Koksal H, Walchli S (2017)
    Fishing therapeutic T-cell receptors in healthy donor blood, is safety predictable?
    Transl. Cancer Res., 6 3, S622-S624
  68. Koller M, Hjermstad MJ, Tomaszewski KA, Tomaszewska IM, Hornslien K, Harle A, Arraras JI, Morag O, Pompili C, Ioannidis G, Georgiou M, Navarra C, Chie WC, Johnson CD, Himpel A, Schulz C, Bohrer T, Janssens A, Kulis D, Bottomley A, (2017)
    An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients
    Ann Oncol, 28 (11), 2874-2881
    DOI 10.1093/annonc/mdx453, PubMed 28945875
  69. Kristensen A, Solheim TS, Amundsen T, Hjelde HH, Kaasa S, Sørhaug S, Grønberg BH (2017)
    Measurement of health-related quality of life during chemotherapy - the importance of timing
    Acta Oncol, 56 (5), 737-745
    DOI 10.1080/0284186X.2017.1279748, PubMed 28117614
  70. Kristian A, Holtedahl JE, Torheim T, Futsaether C, Hernes E, Engebraaten O, Mælandsmo GM, Malinen E (2017)
    Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts
    Mol Imaging Biol, 19 (2), 271-279
    DOI 10.1007/s11307-016-0998-x, PubMed 27541026
  71. König M, Osnes T, Jebsen P, Evensen JF, Meling TR (2017)
    Olfactory neuroblastoma: a single-center experience
    Neurosurg Rev, 41 (1), 323-331
    DOI 10.1007/s10143-017-0859-3, PubMed 28540633
  72. Kaasa S, Knudsen AK, Lundeby T, Loge JH (2017)
    Integration between oncology and palliative care: a plan for the next decade?
    Tumori, 103 (1), 1-8
    DOI 10.5301/tj.5000602, PubMed 28085176
  73. Kaasa S, Knudsen AK, Lundeby T, Loge JHV (2017)
    Author's reply to: Integration between oncology and palliative care: a plan for the next decade?
    Tumori, 103 (3), e24
    DOI 10.5301/tj.5000631, PubMed 28430353
  74. Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA (2017)
    Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
    Colorectal Dis, 19 (8), 731-738
    DOI 10.1111/codi.13622, PubMed 28181384
  75. Labori KJ, Lassen K, Hoem D, Grønbech JE, Søreide JA, Mortensen K, Smaaland R, Sorbye H, Verbeke C, Dueland S (2017)
    Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
    BMC Surg, 17 (1), 94
    DOI 10.1186/s12893-017-0291-1, PubMed 28841916
  76. Leivonen SK, Icay K, Jäntti K, Siren I, Liu C, Alkodsi A, Cervera A, Ludvigsen M, Hamilton-Dutoit SJ, d'Amore F, Karjalainen-Lindsberg ML, Delabie J, Holte H, Lehtonen R, Hautaniemi S, Leppä S (2017)
    MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
    Blood Cancer J, 7 (12), 654
    DOI 10.1038/s41408-017-0033-8, PubMed 29242506
  77. Leivonen SK, Taskinen M, Cervera A, Karjalainen-Lindsberg ML, Delabie J, Holte H, Lehtonen R, Hautaniemi S, Leppä S (2017)
    Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
    Blood Cancer J, 7 (8), e596
    DOI 10.1038/bcj.2017.71, PubMed 28841210
  78. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol, 36 (6), 293-295
    DOI 10.5414/NP301054, PubMed 29035191
  79. Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
    Sci Rep, 7 (1), 5081
    DOI 10.1038/s41598-017-05086-6, PubMed 28698547
  80. Lie HC (2017)
    Mind the Gap: (Unmet) Information needs in cancer care
    Patient Educ Couns, 100 (3), 381-382
    DOI 10.1016/j.pec.2017.02.013, PubMed 28288750
  81. Lie HC, Mellblom AV, Brekke M, Finset A, Fosså SD, Kiserud CE, Ruud E, Loge JH (2017)
    Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma
    Support Care Cancer, 25 (8), 2445-2454
    DOI 10.1007/s00520-017-3651-6, PubMed 28236146
  82. Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM (2017)
    Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
    Cancer Immunol Immunother, 66 (7), 891-901
    DOI 10.1007/s00262-017-1994-y, PubMed 28391357
  83. Loge JH (2017)
    Can one "catch up" in journal?
    Tidsskr. Nor. Laegeforen., 137 (17), 1355
  84. Mellblom AV, Ruud E, Loge JH, Lie HC (2017)
    Do negative emotions expressed during follow-up consultations with adolescent survivors of childhood cancer reflect late effects?
    Patient Educ Couns, 100 (11), 2098-2101
    DOI 10.1016/j.pec.2017.06.008, PubMed 28641990
  85. Meriranta L, Pasanen A, Louhimo R, Cervera A, Alkodsi A, Autio M, Taskinen M, Rantanen V, Karjalainen-Lindsberg ML, Holte H, Delabie J, Lehtonen R, Hautaniemi S, Leppä S (2017)
    Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma
    Haematologica, 102 (5), e195-e198
    DOI 10.3324/haematol.2016.157495, PubMed 28183850
  86. Mezheyeuski A, Strell C, Hrynchyk I, Guren TK, Dragomir A, Doroshenko T, Pashkova O, Gorgun J, Ruksha K, Pfeiffer P, Kure EH, Sorbye H, Edler D, Martling A, Glimelius B, Östman A, Portyanko A (2017)
    Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
    Virchows Arch, 472 (3), 395-405
    DOI 10.1007/s00428-017-2263-3, PubMed 29134439
  87. Mikalsen LTG, Arnesen MR, Bogsrud TV, Dale E, Stokke C (2017)
    Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
    Acta Oncol, 56 (6), 894-897
    DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
  88. Morris JL, Fane A, Sarovich DS, Price EP, Rush CM, Govan BL, Parker E, Mayo M, Currie BJ, Ketheesan N (2017)
    Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia
    Emerg Infect Dis, 23 (5)
    DOI 10.3201/eid2305.151417, PubMed 28418830
  89. Mulvey MR, Boland EG, Bouhassira D, Freynhagen R, Hardy J, Hjermstad MJ, Mercadante S, Pérez C, Bennett MI (2017)
    Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles
    Br J Anaesth, 119 (4), 765-774
    DOI 10.1093/bja/aex175, PubMed 29121284
  90. Mäkitie A, Ruuskanen M, Bentzen J, Brun E, Gebre-Medhin M, Friesland S, Marsk E, Hammarstedt-Nordenvall L, Gille E, Reizenstein J, Adell G, Farnebo L, Rzepecki J, Haugen H, Söderström K, Zackrisson B, Bergström S, Lödén B, Cederblad L, Laurell G, Smeland E, Folkvard Evensen J, Lund JÅ, Tøndel H, Karlsdottir Å et al. (2017)
    The management and survival outcomes of nasopharyngeal cancer in the Nordic countries
    Acta Oncol, 57 (4), 557-560
    DOI 10.1080/0284186X.2017.1408961, PubMed 29202641
  91. Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C (2017)
    Head and neck cancer management in the Nordic countries: an effort to harmonize treatment
    Eur Arch Otorhinolaryngol, 274 (5), 2363-2365
    DOI 10.1007/s00405-017-4456-4, PubMed 28124110
  92. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
    Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
    BMC Cancer, 17 (1), 29
    DOI 10.1186/s12885-016-2992-8, PubMed 28061772
  93. Nestvold J, Wang MY, Camilio KA, Zinöcker S, Tjelle TE, Lindberg A, Haug BE, Kvalheim G, Sveinbjørnsson B, Rekdal Ø (2017)
    Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
    Oncoimmunology, 6 (8), e1338236
    DOI 10.1080/2162402X.2017.1338236, PubMed 28920000
  94. Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N (2017)
    Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
    Clin Biochem, 52, 73-79
    DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759
  95. Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
    Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
    Breast Cancer Res, 19 (1), 120
    DOI 10.1186/s13058-017-0911-9, PubMed 29137653
  96. Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2017)
    Intake of a Protein-Enriched Milk and Effects on Muscle Mass and Strength. A 12-Week Randomized Placebo Controlled Trial among Community-Dwelling Older Adults
    J Nutr Health Aging, 21 (10), 1160-1169
    DOI 10.1007/s12603-016-0856-1, PubMed 29188875
  97. Paque K, Elseviers M, Vander Stichele R, Pardon K, Hjermstad MJ, Kaasa S, Dilles T, De Laat M, Van Belle S, Christiaens T, Deliens L (2017)
    Changes in medication use in a cohort of patients with advanced cancer: The international multicentre prospective European Palliative Care Cancer Symptom study
    Palliat Med, 32 (4), 775-785
    DOI 10.1177/0269216317746843, PubMed 29243546
  98. Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS et al. (2017)
    Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
    Eur Urol, 73 (3), 427-435
    DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540
  99. Paulsen Ø, Laird B, Aass N, Lea T, Fayers P, Kaasa S, Klepstad P (2017)
    The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
    PLoS One, 12 (5), e0177620
    DOI 10.1371/journal.pone.0177620, PubMed 28542626
  100. Planchard D, Smit EF, Groen HJM, Mazieres J, Besse B, Helland Å, Giannone V, D'Amelio AM, Zhang P, Mookerjee B, Johnson BE (2017)
    Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
    Lancet Oncol, 18 (10), 1307-1316
    DOI 10.1016/S1470-2045(17)30679-4, PubMed 28919011
  101. Pulkka OP, Nilsson B, Sarlomo-Rikala M, Reichardt P, Eriksson M, Hall KS, Wardelmann E, Vehtari A, Joensuu H, Sihto H (2017)
    SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
    Br J Cancer, 116 (9), 1195-1202
    DOI 10.1038/bjc.2017.82, PubMed 28334729
  102. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
  103. Reinertsen KV, Loge JH, Brekke M, Kiserud CE (2017)
    Chronic fatigue in adult cancer survivors
    Tidsskr Nor Laegeforen, 137 (21)
    DOI 10.4045/tidsskr.17.0040, PubMed 29135175
  104. Reinertsen KV, Loge JH, Brekke M, Kiserud CE (2017)
    Chronic fatigue in adult cancer survivors
    Tidsskr. Nor. Laegeforen., 137 (21), 1701-1704
  105. Rusten E, Rekstad BL, Undseth C, Al-Haidari G, Hanekamp B, Hernes E, Hellebust TP, Malinen E, Guren MG (2017)
    Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography
    Radiat Oncol, 12 (1), 147
    DOI 10.1186/s13014-017-0883-z, PubMed 28874205
  106. Saldova R, Haakensen VD, Rødland E, Walsh I, Stöckmann H, Engebraaten O, Børresen-Dale AL, Rudd PM (2017)
    Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up
    Mol Oncol, 11 (10), 1361-1379
    DOI 10.1002/1878-0261.12105, PubMed 28657165
  107. Sandmael JA, Bye A, Solheim TS, Stene GB, Thorsen L, Kaasa S, Lund JÅ, Oldervoll LM (2017)
    Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial
    Cancer, 123 (22), 4440-4448
    DOI 10.1002/cncr.30901, PubMed 28759113
  108. Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C (2017)
    An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
    Ann Oncol, 28 (5), 1090-1097
    DOI 10.1093/annonc/mdx044, PubMed 28453701
  109. Schive SW, Mirlashari MR, Hasvold G, Wang M, Josefsen D, Gullestad HP, Korsgren O, Foss A, Kvalheim G, Scholz H (2017)
    Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo
    Cell Med, 9 (3), 103-116
    DOI 10.3727/215517917X693401, PubMed 28713640
  110. Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Borgen E, Naume B, Brudvik KW, Wiedswang G (2017)
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
    Ann Surg Oncol, 24 (8), 2113-2121
    DOI 10.1245/s10434-017-5818-2, PubMed 28258416
  111. Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE (2017)
    Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
    Acta Oncol, 56 (4), 590-598
    DOI 10.1080/0284186X.2016.1267870, PubMed 28077016
  112. Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
    The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
    Clin Cancer Res, 23 (16), 4662-4670
    DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444
  113. Skalleberg J, Solheim O, Fosså SD, Småstuen MC, Osnes T, Gundersen POM, Bunne M (2017)
    Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
    Gynecol Oncol, 145 (1), 148-153
    DOI 10.1016/j.ygyno.2017.02.006, PubMed 28202195
  114. Smeland KH (2017)
    Overlevelse og seneffekter etter lymfombehandling
    Tidsskr Nor Laegeforen, 137 (6), 470
    DOI 10.4045/tidsskr.16.1111, PubMed 28332807
  115. Sodergren SC, Johnson CD, Gilbert A, Tomaszewski KA, Chu W, Chung HT, Dennis K, Desideri I, Glynne-Jones R, Grønlie Guren M, Kardamakis D, Nugent K, Schmidt H, Sebag-Montefiore D, Vassiliou V, EORTC Quality of Life Group (2017)
    Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer
    Radiother Oncol, 126 (2), 222-228
    DOI 10.1016/j.radonc.2017.11.018, PubMed 29217122
  116. Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, Kaasa S (2017)
    A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
    J Cachexia Sarcopenia Muscle, 8 (5), 778-788
    DOI 10.1002/jcsm.12201, PubMed 28614627
  117. Sonke GS, Hart LL, Campone M, Erdkamp F, Janni W, Verma S, Villanueva C, Jakobsen E, Alba E, Wist E, Favret AM, Bachelot T, Hegg R, Wheatley-Price P, Souami F, Sutradhar S, Miller M, Germa C, Burris HA (2017)
    Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
    Breast Cancer Res Treat, 167 (3), 659-669
    DOI 10.1007/s10549-017-4523-y, PubMed 29058175
  118. Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A (2017)
    Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
    Oncologist, 23 (1), 62-70
    DOI 10.1634/theoncologist.2017-0161, PubMed 28754721
  119. Steen R, Dahl AA, Hess SL, Kiserud CE (2017)
    A study of chronic fatigue in Norwegian cervical cancer survivors
    Gynecol Oncol, 146 (3), 630-635
    DOI 10.1016/j.ygyno.2017.05.028, PubMed 28552254
  120. Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy SO, Wethal T, Kiserud CE, Samersaw-Lund MB (2017)
    Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
    Acta Oncol, 57 (6), 773-781
    DOI 10.1080/0284186X.2017.1406137, PubMed 29171324
  121. Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P (2017)
    Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment
    Acta Oncol, 56 (5), 698-705
    DOI 10.1080/0284186X.2017.1301679, PubMed 28325133
  122. Sternby Eilard M, Hagström H, Mortensen KE, Wilsgaard T, Vagnildhaug OM, Dajani O, Stål P, Rizell M (2017)
    Quality of life as a prognostic factor for survival in hepatocellular carcinoma
    Liver Int, 38 (5), 885-894
    DOI 10.1111/liv.13593, PubMed 28941130
  123. Thomsen M, Guren MG, Skovlund E, Glimelius B, Hjermstad MJ, Johansen JS, Kure E, Sorbye H, Pfeiffer P, Christoffersen T, Guren TK, Tveit KM (2017)
    Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status
    Eur J Cancer, 81, 26-35
    DOI 10.1016/j.ejca.2017.04.026, PubMed 28595137
  124. Thorsen L, Kirkegaard C, Loge JH, Kiserud CE, Johansen ML, Gjerset GM, Edvardsen E, Hamre H, Ikdahl T, Fosså SD (2017)
    Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
    BMC Res Notes, 10 (1), 214
    DOI 10.1186/s13104-017-2531-y, PubMed 28619116
  125. Trovik C, Bauer HCF, Styring E, Sundby Hall K, Vult Von Steyern F, Eriksson S, Johansson I, Sampo M, Laitinen M, Kalén A, Jónsson H, Jebsen N, Eriksson M, Tukiainen E, Wall N, Zaikova O, Sigurðsson H, Lehtinen T, Bjerkehagen B, Skorpil M, Egil Eide G, Johansson E, Alvegard TA (2017)
    The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
    Acta Orthop, 88 (3), 341-347
    DOI 10.1080/17453674.2017.1293441, PubMed 28266233
  126. Vagnildhaug OM, Balstad TR, Almberg SS, Brunelli C, Knudsen AK, Kaasa S, Thronæs M, Laird B, Solheim TS (2017)
    A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer
    Support Care Cancer, 26 (6), 1871-1880
    DOI 10.1007/s00520-017-4022-z, PubMed 29274028
  127. Vagnildhaug OM, Blum D, Wilcock A, Fayers P, Strasser F, Baracos VE, Hjermstad MJ, Kaasa S, Laird B, Solheim TS, European Palliative Care Cancer Symptom study group (2017)
    The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
    J Cachexia Sarcopenia Muscle, 8 (5), 789-797
    DOI 10.1002/jcsm.12220, PubMed 28627024
  128. Van Laethem JL, Riess H, Jassem J, Haas M, Martens UM, Weekes C, Peeters M, Ross P, Bridgewater J, Melichar B, Cascinu S, Saramak P, Michl P, Van Brummelen D, Zaniboni A, Schmiegel W, Dueland S, Giurescu M, Garosi VL, Roth K, Schulz A, Seidel H, Rajagopalan P, Teufel M, Childs BH (2017)
    Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
    Target Oncol, 12 (1), 97-109
    DOI 10.1007/s11523-016-0469-y, PubMed 27975152
  129. van Leeuwen M, Kieffer JM, Efficace F, Fosså SD, Bolla M, Collette L, Colombel M, De Giorgi U, Holzner B, van de Poll-Franse LV, van Poppel H, White J, de Wit R, Osanto S, Aaronson NK, European Organisation for Research and Treatment of Cancer Quality of Life Group, Genito-Urinary Cancers Group and Radiation Oncology Group, and the NCRN Testis Clinical Studies Group (2017)
    International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer
    Health Qual Life Outcomes, 15 (1), 97
    DOI 10.1186/s12955-017-0670-4, PubMed 28490338
  130. Vandraas KF, Torfoss D, Berstad AE, Horndalsveen H, Turowski G (2017)
    Cancer patient in the 50s with troublesome palpitations
    Tidsskr. Nor. Laegeforen., 137 (16), 1210-1213
  131. Vatne K, Stensvold A, Myklebust TÅ, Møller B, Svindland A, Kvåle R, Fosså SD (2017)
    Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study
    Acta Oncol, 56 (10), 1295-1301
    DOI 10.1080/0284186X.2017.1314006, PubMed 28422584
  132. Vaysse C, Lomo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husoy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
    npj Breast Cancer, 3, UNSP 35
  133. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 35
    DOI 10.1038/s41523-017-0030-x, PubMed 28884144
  134. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 19
    DOI 10.1038/s41523-017-0015-9, PubMed 28649659
  135. Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S (2017)
    A TCR-based Chimeric Antigen Receptor
    Sci Rep, 7 (1), 10713
    DOI 10.1038/s41598-017-11126-y, PubMed 28878363
  136. Wogsland CE, Greenplate AR, Kolstad A, Myklebust JH, Irish JM, Huse K (2017)
    Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations
    Cytometry B Clin Cytom, 92 (1), 79-87
    DOI 10.1002/cyto.b.21498, PubMed 27933753
  137. Ødegård J, Sondresen JE, Aasrum M, Tveteraas IH, Guren TK, Christoffersen T, Thoresen GH (2017)
    Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes
    Growth Factors, 35 (6), 239-248
    DOI 10.1080/08977194.2018.1453506, PubMed 29582692
  138. Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
    Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
    Urology, 110, 140-147
    DOI 10.1016/j.urology.2017.07.048, PubMed 28823634
  139. Åsli LM, Johannesen TB, Myklebust TÅ, Møller B, Eriksen MT, Guren MG (2017)
    Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - A population-based study
    Radiother Oncol, 123 (3), 446-453
    DOI 10.1016/j.radonc.2017.04.012, PubMed 28483302

Publications 2016

  1. Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbæk K, Sundberg J, Pedersen LB, Ralfkiær E, Karjalainen-Lindsberg ML, Sundström C, Ehinger M, Geisler C, Jerkeman M (2016)
    Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
    Blood, 128 (14), 1814-1820
    DOI 10.1182/blood-2016-03-704023, PubMed 27354719
  2. Ardizzoni A, Tiseo M, Boni L, Di Maio M, Buffoni L, Belvedere O, Grossi F, D'Alessandro V, de Marinis F, Barbera S, Caroti C, Favaretto A, Cortinovis D, Morrica B, Tixi L, Ceschia T, Parisi S, Ricardi U, Grimaldi A, Loreggian L, Navarria P, Huber RM, Belani C, Brunsvig PF, Scagliotti GV et al. (2016)
    Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC
    Lung Cancer, 100, 30-37
    DOI 10.1016/j.lungcan.2016.07.026, PubMed 27597278
  3. Arnesen MR, Rekstad BL, Stokke C, Bruheim K, Løndalen AM, Hellebust TP, Malinen E (2016)
    Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
    Radiat Oncol, 11, 39
    DOI 10.1186/s13014-016-0612-z, PubMed 26968827
  4. Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjövall A, Brge Johannesen T, Moreau M, Gabriel L, Gonçalves AF, Bento MJ, van de Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H (2016)
    Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes
    Medicine (Baltimore), 95 (22), e3812
    DOI 10.1097/MD.0000000000003812, PubMed 27258522
  5. Bandera EV, Fay SH, Giovannucci E, Leitzmann MF, Marklew R, McTiernan A, Mullee A, Romieu I, Thune I, Uauy R, Wiseman MJ, World Cancer Research Fund International Continuous Update Project Panel (2016)
    The use and interpretation of anthropometric measures in cancer epidemiology: A perspective from the world cancer research fund international continuous update project
    Int J Cancer, 139 (11), 2391-7
    DOI 10.1002/ijc.30248, PubMed 27352197
  6. Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, Brun E, Hjorthaug K, Viney ZN, Pike LC, Federico M, Luminari S, Radford J, Trotman J, Fosså A, Berkahn L, Molin D, D'Amore F, Sinclair DA, Smith P, O'Doherty MJ, Stevens L, Johnson PW (2016)
    PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
    Blood, 127 (12), 1531-8
    DOI 10.1182/blood-2015-11-679407, PubMed 26747247
  7. Barzenje DA, Holte H, Fosså A, Ghanima W, Liestøl K, Delabie J, Kolstad A (2016)
    Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma
    Leuk Lymphoma, 58 (3), 623-632
    DOI 10.1080/10428194.2016.1204653, PubMed 27389974
  8. Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA (2016)
    Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
    PLoS One, 11 (9), e0163859
    DOI 10.1371/journal.pone.0163859, PubMed 27685995
  9. Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ, International Consortium for End-of-Life Research (ICELR) (2016)
    Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries
    JAMA, 315 (3), 272-83
    DOI 10.1001/jama.2015.18603, PubMed 26784775
  10. Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Wälchli S, König S, Salazar AM, Hartley O, Dietrich PY, Walker PR, Derouazi M (2016)
    Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants
    Mol Ther, 24 (9), 1675-85
    DOI 10.1038/mt.2016.134, PubMed 27377043
  11. Blaker YN, Spetalen S, Brodtkorb M, Lingjaerde OC, Beiske K, Østenstad B, Sander B, Wahlin BE, Melen CM, Myklebust JH, Holte H, Delabie J, Smeland EB (2016)
    The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
    Br J Haematol, 175 (1), 102-14
    DOI 10.1111/bjh.14201, PubMed 27341313
  12. Blakkisrud J, Løndalen A, Dahle J, Turner S, Holte H, Kolstad A, Stokke C (2016)
    Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate
    J Nucl Med, 58 (1), 55-61
    DOI 10.2967/jnumed.116.180471, PubMed 27587710
  13. Blakkisrud J, Løndalen A, Martinsen AC, Dahle J, Holtedahl JE, Bach-Gansmo T, Holte H, Kolstad A, Stokke C (2016)
    Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    J Nucl Med, 58 (1), 48-54
    DOI 10.2967/jnumed.116.173922, PubMed 27493270
  14. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
    Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
    Cancer Med, 5 (8), 1840-9
    DOI 10.1002/cam4.766, PubMed 27273130
  15. Boysen ME, Zätterström UK, Evensen JF (2016)
    Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases
    Anticancer Res, 36 (6), 2849-54
    PubMed 27272796
  16. Brandstorp-Boesen J, Sørum Falk R, Folkvard Evensen J, Boysen M, Brøndbo K (2016)
    Risk of Recurrence in Laryngeal Cancer
    PLoS One, 11 (10), e0164068
    DOI 10.1371/journal.pone.0164068, PubMed 27716797
  17. Brelin S, Fredheim OM, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2016)
    Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study
    J Opioid Manag, 12 (1), 25-36
    DOI 10.5055/jom.2016.0309, PubMed 26908301
  18. Brenne E, Loge JH, Lie H, Hjermstad MJ, Fayers PM, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2016)
    The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer
    Palliat Med, 30 (6), 587-98
    DOI 10.1177/0269216315620082, PubMed 26763008
  19. Brustugun OT (2016)
    Stratification in advanced non-small cell lung cancer: precision medicine in practice
    Expert Rev. Precis. Med. Drug Dev., 1 (3), 279-287
  20. Brustugun OT, Sprauten M, Helland Å (2016)
    Real-world data on nivolumab treatment of non-small cell lung cancer
    Acta Oncol, 56 (3), 438-440
    DOI 10.1080/0284186X.2016.1253865, PubMed 27892773
  21. Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvão DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Lucia A, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L et al. (2016)
    Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
    Cancer Treat Rev, 52, 91-104
    DOI 10.1016/j.ctrv.2016.11.010, PubMed 28006694
  22. Bye A, Wesseltoft-Rao N, Iversen PO, Skjegstad G, Holven KB, Ulven S, Hjermstad MJ (2016)
    Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer
    Med Oncol, 33 (6), 54
    DOI 10.1007/s12032-016-0768-2, PubMed 27119533
  23. Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A (2016)
    Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation
    Ecancermedicalscience, 10, 691
    DOI 10.3332/ecancer.2016.691, PubMed 27994647
  24. Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG (2016)
    Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study
    Acta Oncol, 55 (12), 1400-1407
    DOI 10.1080/0284186X.2016.1191666, PubMed 27332723
  25. Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, Hämmerling GJ (2016)
    Corrigendum: Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells
    Nat Immunol, 17 (2), 214
    DOI 10.1038/ni0216-214b, PubMed 26784268
  26. Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Fosså SD, Ruud E, Kiserud CE, Aakhus S (2016)
    Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia
    Am J Cardiol, 118 (3), 446-52
    DOI 10.1016/j.amjcard.2016.05.021, PubMed 27296561
  27. Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Ruud E, Kiserud CE, Fosså SD, Aakhus S (2016)
    Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia
    Eur Heart J Cardiovasc Imaging, 17 (7), 735-41
    DOI 10.1093/ehjci/jew018, PubMed 26917232
  28. Coiffier B, Thieblemont C, de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, Morschhauser F, Navarro R, Le Gouill S, Haioun C, Houot R, Casasnovas O, Holte H, Lamy T, Broussais F, Payrard S, Hatteville L, Tilly H (2016)
    A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
    Br J Haematol, 173 (5), 722-30
    DOI 10.1111/bjh.13992, PubMed 27010483
  29. Dahl AA (2016)
    My anxiety Fear, hope, dread and peace of mind
    Tidsskr. Nor. Laegeforen., 136 (5), 453
  30. Dahl AA, Østby-Deglum M, Oldenburg J, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2016)
    Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
    J Cancer Surviv, 10 (5), 842-9
    DOI 10.1007/s11764-016-0529-4, PubMed 26920871
  31. Dale E, Moan JM, Osnes TA, Bogsrud TV (2016)
    Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome
    Eur Arch Otorhinolaryngol, 274 (2), 1015-1019
    DOI 10.1007/s00405-016-4318-5, PubMed 27671150
  32. Davidson B, Valborg Reinertsen K, Trinh D, Reed W, Bøhler PJ (2016)
    BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma
    Hum Pathol, 54, 64-73
    DOI 10.1016/j.humpath.2016.02.023, PubMed 27038683
  33. Demeulemeester J, Kumar P, Møller EK, Nord S, Wedge DC, Peterson A, Mathiesen RR, Fjelldal R, Zamani Esteki M, Theunis K, Fernandez Gallardo E, Grundstad AJ, Borgen E, Baumbusch LO, Børresen-Dale AL, White KP, Kristensen VN, Van Loo P, Voet T, Naume B (2016)
    Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
    Genome Biol, 17 (1), 250
    DOI 10.1186/s13059-016-1109-7, PubMed 27931250
  34. Dueland S, Ree AH, Grøholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K (2016)
    Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
    Clin Oncol (R Coll Radiol), 28 (8), 532-9
    DOI 10.1016/j.clon.2016.01.014, PubMed 26888115
  35. Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
    Expression and clinical significance of Wee1 in colorectal cancer
    Tumour Biol, 37 (9), 12133-12140
    DOI 10.1007/s13277-016-5081-3, PubMed 27220319
  36. Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å (2016)
    The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes
    BMC Cancer, 16, 71
    DOI 10.1186/s12885-016-2104-9, PubMed 26858029
  37. Eide HA, Halvorsen AR, Sandhu V, Fåne A, Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA, Helland Å (2016)
    Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
    Clin Transl Immunology, 5 (11), e109
    DOI 10.1038/cti.2016.65, PubMed 27990285
  38. Ekström M, Johnson MJ, Schiöler L, Kaasa S, Hjermstad MJ, Currow DC (2016)
    Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study
    Support Care Cancer, 24 (9), 3803-11
    DOI 10.1007/s00520-016-3207-1, PubMed 27061408
  39. Elvsåshagen T, Zuzarte P, Westlye LT, Bøen E, Josefsen D, Boye B, Hol PK, Malt UF, Young LT, Andreazza AC (2016)
    Dentate gyrus-cornu ammonis (CA) 4 volume is decreased and associated with depressive episodes and lipid peroxidation in bipolar II disorder: Longitudinal and cross-sectional analyses
    Bipolar Disord, 18 (8), 657-668
    DOI 10.1111/bdi.12457, PubMed 27995733
  40. Eriksson M, Reichardt P, Sundby Hall K, Schütte J, Cameron S, Hohenberger P, Bauer S, Leinonen M, Reichardt A, Rejmyr Davis M, Alvegård T, Joensuu H (2016)
    Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?
    Eur J Cancer, 59, 128-133
    DOI 10.1016/j.ejca.2016.02.021, PubMed 27033260
  41. Eskelund CW, Kolstad A, Jerkeman M, Räty R, Laurell A, Eloranta S, Smedby KE, Husby S, Pedersen LB, Andersen NS, Eriksson M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Workman CT, Garde C, Elonen E, Brown P et al. (2016)
    15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
    Br J Haematol, 175 (3), 410-418
    DOI 10.1111/bjh.14241, PubMed 27378674
  42. Espinoza JA, Jabeen S, Batra R, Papaleo E, Haakensen V, Timmermans Wielenga V, Møller Talman ML, Brunner N, Børresen-Dale AL, Gromov P, Helland Å, Kristensen VN, Gromova I (2016)
    Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics
    Oncoimmunology, 5 (12), e1248015
    DOI 10.1080/2162402X.2016.1248015, PubMed 28123884
  43. Fjeldheim FN, Frydenberg H, Flote VG, McTiernan A, Furberg AS, Ellison PT, Barrett ES, Wilsgaard T, Jasienska G, Ursin G, Wist EA, Thune I (2016)
    Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes
    BMC Cancer, 16 (1), 776
    DOI 10.1186/s12885-016-2804-1, PubMed 27717337
  44. Flatmark K, Saelen MG, Hole KH, Abrahamsen TW, Fleten KG, Hektoen HH, Redalen KR, Seierstad T, Dueland S, Ree AH (2016)
    Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
    Radiother Oncol, 119 (3), 505-11
    DOI 10.1016/j.radonc.2016.02.020, PubMed 26968754
  45. Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
    Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
    Lipids Health Dis, 15, 56
    DOI 10.1186/s12944-016-0225-4, PubMed 26970778
  46. Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O et al. (2016)
    Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome
    JCI Insight, 1 (21), e89376
    DOI 10.1172/jci.insight.89376, PubMed 28018972
  47. Fosså SD, Bengtsson T, Borre M, Ahlgren G, Rannikko A, Dahl AA (2016)
    Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries
    Scand J Urol, 50 (5), 330-7
    DOI 10.1080/21681805.2016.1201859, PubMed 27398736
  48. Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA (2016)
    Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
    Scand J Urol, 50 (4), 280-5
    DOI 10.3109/21681805.2016.1163617, PubMed 27049891
  49. Fosså SD, Wiklund F, Klepp O, Angelsen A, Solberg A, Damber JE, Hoyer M, Widmark A, The Scandinavian Prostate Cancer Group-7 Investigators (2016)
    Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
    Eur Urol, 70 (4), 684-691
    DOI 10.1016/j.eururo.2016.03.021, PubMed 27025586
  50. Fredheim OM, Brelin S, Hjermstad MJ, Loge JH, Aass N, Johannesen TB, Skurtveit S (2016)
    Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
    Eur J Pain, 21 (3), 530-540
    DOI 10.1002/ejp.956, PubMed 27739657
  51. Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, Risberg T, Wist EA, Flote VG, Furberg AS, Wilsgaard T, Akslen LA, McTiernan A (2016)
    Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival
    Breast Cancer Res Treat, 155 (2), 345-54
    DOI 10.1007/s10549-015-3671-1, PubMed 26740213
  52. Frøysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K (2016)
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort
    J Surg Oncol, 114 (2), 222-7
    DOI 10.1002/jso.24290, PubMed 27173150
  53. Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB (2016)
    Reply to S. Alanee et al
    J Clin Oncol, 34 (11), 1285-6
    DOI 10.1200/JCO.2015.65.7015, PubMed 26858338
  54. Glimelius B, Myklebust TÅ, Lundqvist K, Wibe A, Guren MG (2016)
    Two countries - Two treatment strategies for rectal cancer
    Radiother Oncol, 121 (3), 357-363
    DOI 10.1016/j.radonc.2016.11.010, PubMed 27887734
  55. Gotaas HT, Skeie GO, Gilhus NE (2016)
    Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap
    Neuromuscul Disord, 26 (6), 337-41
    DOI 10.1016/j.nmd.2016.03.003, PubMed 27102003
  56. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    Eur Heart J, 37 (21), 1671-80
    DOI 10.1093/eurheartj/ehw022, PubMed 26903532
  57. Halvorsen AR, Bjaanæs M, LeBlanc M, Holm AM, Bolstad N, Rubio L, Peñalver JC, Cervera J, Mojarrieta JC, López-Guerrero JA, Brustugun OT, Helland Å (2016)
    A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer
    Oncotarget, 7 (24), 37250-37259
    DOI 10.18632/oncotarget.9363, PubMed 27191990
  58. Halvorsen AR, Helland Å, Gromov P, Wielenga VT, Talman MM, Brunner N, Sandhu V, Børresen-Dale AL, Gromova I, Haakensen VD (2016)
    Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer
    Mol Oncol, 11 (2), 220-234
    DOI 10.1002/1878-0261.12025, PubMed 28145100
  59. Halvorsen AR, Silwal-Pandit L, Meza-Zepeda LA, Vodak D, Vu P, Sagerup C, Hovig E, Myklebost O, Børresen-Dale AL, Brustugun OT, Helland Å (2016)
    TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
    Front Genet, 7, 85
    DOI 10.3389/fgene.2016.00085, PubMed 27242894
  60. Halvorsen TO, Herje M, Levin N, Bremnes RM, Brustugun OT, Fløtten Ø, Kaasa S, Sundstrøm S, Grønberg BH (2016)
    Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
    Lung Cancer, 102, 9-14
    DOI 10.1016/j.lungcan.2016.10.003, PubMed 27987595
  61. Halvorsen TO, Sundstrøm S, Fløtten Ø, Brustugun OT, Brunsvig P, Aasebø U, Bremnes RM, Kaasa S, Grønberg BH (2016)
    Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer
    Acta Oncol, 55 (11), 1349-1354
    DOI 10.1080/0284186X.2016.1201216, PubMed 27549509
  62. Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt V, Baynes C, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, NBCS Collaborators, Couch FJ et al. (2016)
    Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
    Oncotarget, 7 (49), 80140-80163
    DOI 10.18632/oncotarget.12818, PubMed 27792995
  63. Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF, Oslo Breast Cancer Consortium (OSBREAC) (2016)
    Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes
    Cancer Metab, 4, 12
    DOI 10.1186/s40170-016-0152-x, PubMed 27350877
  64. Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM et al. (2016)
    Increased pancreatic cancer risk following radiotherapy for testicular cancer
    Br J Cancer, 115 (7), 901-8
    DOI 10.1038/bjc.2016.272, PubMed 27599043
  65. Hjelle LV, Bremnes RM, Gundersen POM, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Haugnes HS (2016)
    Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
    Urol Oncol, 34 (11), 487.e13-487.e20
    DOI 10.1016/j.urolonc.2016.06.012, PubMed 27523611
  66. Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, EORTC QoL Group (2016)
    International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15
    Support Care Cancer, 24 (9), 3915-24
    DOI 10.1007/s00520-016-3216-0, PubMed 27113466
  67. Hjermstad MJ, Kaasa S, Caraceni A, Loge JH, Pedersen T, Haugen DF, Aass N, European Palliative Care Research Collaborative (EPCRC) (2016)
    Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer
    BMJ Support Palliat Care, 6 (3), 344-52
    DOI 10.1136/bmjspcare-2015-000887, PubMed 27342412
  68. Hjermstad MJ, Aass N, Aielli F, Bennett M, Brunelli C, Caraceni A, Cavanna L, Fassbender K, Feio M, Haugen DF, Jakobsen G, Laird B, Løhre ET, Martinez M, Nabal M, Noguera-Tejedor A, Pardon K, Pigni A, Piva L, Porta-Sales J, Rizzi F, Rondini E, Sjøgren P, Strasser F, Turriziani A et al. (2016)
    Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research
    BMJ Support Palliat Care, 8 (4), 456-467
    DOI 10.1136/bmjspcare-2015-000997, PubMed 27246166
  69. Holm KL, Indrevaer RL, Myklebust JH, Kolstad A, Moskaug JØ, Naderi EH, Blomhoff HK (2016)
    Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis
    Immunology, 149 (1), 62-73
    DOI 10.1111/imm.12629, PubMed 27278254
  70. Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K (2016)
    Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
    Clin Sarcoma Res, 6, 21
    DOI 10.1186/s13569-016-0062-2, PubMed 27999655
  71. Hougsnæs S, Bøe HJ, Dahl AA, Reichelt JG (2016)
    Norwegian male military veterans show low levels of mental health problems four years after deployment in Afghanistan
    Nord J Psychiatry, 71 (1), 26-32
    DOI 10.1080/08039488.2016.1201529, PubMed 27356042
  72. Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E (2016)
    Referral criteria for outpatient specialty palliative cancer care: an international consensus
    Lancet Oncol, 17 (12), e552-e559
    DOI 10.1016/S1470-2045(16)30577-0, PubMed 27924753
  73. Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K (2016)
    Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine
    Br J Surg, 103 (6), 684-691
    DOI 10.1002/bjs.10104, PubMed 26988241
  74. Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å (2016)
    Subtype-specific micro-RNA expression signatures in breast cancer progression
    Int J Cancer, 139 (5), 1117-28
    DOI 10.1002/ijc.30142, PubMed 27082076
  75. Iversen A, Frydenberg H, Furberg AS, Flote VG, Finstad SE, McTiernan A, Ursin G, Wilsgaard T, Ellison PT, Jasienska G, Thune I (2016)
    Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women
    Eur J Cancer Prev, 25 (1), 9-18
    DOI 10.1097/CEJ.0000000000000130, PubMed 25714648
  76. Jacobsen EL, Brovold T, Bergland A, Bye A (2016)
    Prevalence of factors associated with malnutrition among acute geriatric patients in Norway: a cross-sectional study
    BMJ Open, 6 (9), e011512
    DOI 10.1136/bmjopen-2016-011512, PubMed 27601491
  77. Jeppesen E, Bjelland I, Fosså SD, Loge JH, Dahl AA (2016)
    Health-related quality of life in teenagers with a parent with cancer
    Eur J Oncol Nurs, 22, 46-53
    DOI 10.1016/j.ejon.2016.03.004, PubMed 27179892
  78. Jerusalem G, Mariani G, Ciruelos EM, Martin M, Tjan-Heijnen VC, Neven P, Gavila JG, Michelotti A, Montemurro F, Generali D, Simoncini E, Lang I, Mardiak J, Naume B, Camozzi M, Lorizzo K, Bianchetti S, Conte P (2016)
    Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
    Ann Oncol, 27 (9), 1719-25
    DOI 10.1093/annonc/mdw249, PubMed 27358383
  79. Ji Y, Li X, Li Y, Zhong Y, Cao J, Xu R, Wang J, Zhou F, Li X, Yu D, Wen JG, Goscinski MA, Zhang M, Nesland JM, Suo Z (2016)
    Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma
    Anticancer Res, 36 (1), 343-9
    PubMed 26722063
  80. Johannsdottir IM, Karlstad Ø, Loge JH, Fosså SD, Kiserud C, Skurtveit S (2016)
    Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
    J Adolesc Young Adult Oncol, 6 (1), 120-126
    DOI 10.1089/jayao.2016.0041, PubMed 27841952
  81. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2016)
    Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012
    Pediatr Radiol, 47 (1), 82-88
    DOI 10.1007/s00247-016-3720-x, PubMed 27815616
  82. Joly-Battaglini A, Hammarström C, Stankovic B, Aamodt H, Stjärne J, Brustugun OT, Helland Å, Øynebråten I, Corthay A (2016)
    Rituximab efficiently depletes B cells in lung tumors and normal lung tissue
    F1000Res, 5, 38
    DOI 10.12688/f1000research.7599.1, PubMed 27081474
  83. Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH (2016)
    Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
    BMC Cancer, 16, 536
    DOI 10.1186/s12885-016-2601-x, PubMed 27461255
  84. Kalanxhi E, Risberg K, Barua IS, Dueland S, Waagene S, Andersen SN, Pettersen SJ, Lindvall JM, Redalen KR, Flatmark K, Ree AH (2016)
    Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
    Cancer Res Treat, 49 (2), 374-386
    DOI 10.4143/crt.2016.080, PubMed 27488871
  85. Karlsen T, Sandvik L, Heimdal JH, Hjermstad MJ, Aarstad AK, Aarstad HJ (2016)
    Health-related Quality of Life as Studied by EORTC QLQ and Voice Handicap Index Among Various Patients With Laryngeal Disease
    J Voice, 31 (2), 251.e17-251.e26
    DOI 10.1016/j.jvoice.2016.07.009, PubMed 27520510
  86. Kiserud CE, Fagerli UM, Smeland KB, Fluge Ø, Bersvendsen H, Kvaløy S, Holte H, Dahl AA (2016)
    Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation
    Acta Oncol, 55 (5), 547-53
    DOI 10.3109/0284186X.2015.1125015, PubMed 27123741
  87. Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
    A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
    Ann Oncol, 27 (4), 660-7
    DOI 10.1093/annonc/mdw010, PubMed 26782957
  88. Kolstad A, Pedersen LB, Eskelund CW, Husby S, Grønbæk K, Jerkeman M, Laurell A, Räty R, Elonen E, Andersen NS, Brown PD, Kimby E, Bentzen H, Sundström C, Ehinger M, Karjalainen-Lindsberg ML, Delabie J, Ralfkiær E, Fagerli UM, Nilsson-Ehle H, Lauritzsen GF, Kuittinen O, Niemann C, Geisler CH, Nordic Lymphoma Group (2016)
    Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
    Biol Blood Marrow Transplant, 23 (3), 428-435
    DOI 10.1016/j.bbmt.2016.12.634, PubMed 28039078
  89. Korsvold L, Lie HC, Mellblom AV, Ruud E, Loge JH, Finset A (2016)
    Tailoring the delivery of cancer diagnosis to adolescent and young adult patients displaying strong emotions: An observational study of two cases
    Int J Qual Stud Health Well-being, 11, 30763
    DOI 10.3402/qhw.v11.30763, PubMed 27125477
  90. Korsvold L, Mellblom AV, Finset A, Ruud E, Lie HC (2016)
    A content analysis of emotional concerns expressed at the time of receiving a cancer diagnosis: An observational study of consultations with adolescent and young adult patients and their family members
    Eur J Oncol Nurs, 26, 1-8
    DOI 10.1016/j.ejon.2016.10.005, PubMed 28069147
  91. Korsvold L, Mellblom AV, Lie HC, Ruud E, Loge JH, Finset A (2016)
    Patient-provider communication about the emotional cues and concerns of adolescent and young adult patients and their family members when receiving a diagnosis of cancer
    Patient Educ Couns, 99 (10), 1576-83
    DOI 10.1016/j.pec.2016.03.028, PubMed 27139576
  92. Kurita GP, Benthien KS, Sjøgren P, Kaasa S, Hjermstad MJ (2016)
    Identification of the predictors of cognitive impairment in patients with cancer in palliative care: a prospective longitudinal analysis
    Support Care Cancer, 25 (3), 941-949
    DOI 10.1007/s00520-016-3485-7, PubMed 27832369
  93. Kurita GP, Ekholm O, Kaasa S, Klepstad P, Skorpen F, Sjøgren P (2016)
    Genetic variation and cognitive dysfunction in opioid-treated patients with cancer
    Brain Behav, 6 (7), e00471
    DOI 10.1002/brb3.471, PubMed 27247849
  94. Kvammen Ø, Myklebust TÅ, Solberg A, Møller B, Klepp OH, Fosså SD, Tandstad T (2016)
    Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor
    Cancer Epidemiol Biomarkers Prev, 25 (5), 773-9
    DOI 10.1158/1055-9965.EPI-15-1153, PubMed 26908435
  95. Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M (2016)
    T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
    Oncoimmunology, 5 (12), e1249090
    DOI 10.1080/2162402X.2016.1249090, PubMed 28123886
  96. Kyte JA, Aamdal S, Dueland S, Sæbøe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G (2016)
    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
    Oncoimmunology, 5 (11), e1232237
    DOI 10.1080/2162402X.2016.1232237, PubMed 27999747
  97. König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR (2016)
    Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
    Neurosurg Rev, 40 (3), 449-460
    DOI 10.1007/s10143-016-0802-z, PubMed 27858303
  98. Kaasa S (2016)
    Reply to O. Corli et al and M. Lucchesi et al
    J Clin Oncol, 34 (29), 3581-3582
    DOI 10.1200/JCO.2016.67.7534, PubMed 27458292
  99. Laird BJ, Fallon M, Hjermstad MJ, Tuck S, Kaasa S, Klepstad P, McMillan DC (2016)
    Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response
    J Clin Oncol, 34 (23), 2769-75
    DOI 10.1200/JCO.2015.65.7742, PubMed 27354484
  100. Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2016)
    MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
    Oncotarget, 7 (26), 40297-40313
    DOI 10.18632/oncotarget.9610, PubMed 27248169
  101. Lilleby W, Stensvold A, Dahl AA (2016)
    Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer
    Acta Oncol, 55 (7), 807-13
    DOI 10.3109/0284186X.2015.1127417, PubMed 26959297
  102. Laake I, Larsen IK, Selmer R, Thune I, Veierød MB (2016)
    Pre-diagnostic body mass index and weight change in relation to colorectal cancer survival among incident cases from a population-based cohort study
    BMC Cancer, 16, 402
    DOI 10.1186/s12885-016-2445-4, PubMed 27387027
  103. Madeira T, Peixoto-Plácido C, Goulão B, Mendonça N, Alarcão V, Santos N, de Oliveira RM, Yngve A, Bye A, Bergland A, Lopes C, Nicola P, Santos O, Clara JG (2016)
    National survey of the Portuguese elderly nutritional status: study protocol
    BMC Geriatr, 16, 139
    DOI 10.1186/s12877-016-0299-x, PubMed 27423703
  104. Manegold C, Dingemans AC, Gray JE, Nakagawa K, Nicolson M, Peters S, Reck M, Wu YL, Brustugun OT, Crinò L, Felip E, Fennell D, Garrido P, Huber RM, Marabelle A, Moniuszko M, Mornex F, Novello S, Papotti M, Pérol M, Smit EF, Syrigos K, van Meerbeeck JP, van Zandwijk N, Chih-Hsin Yang J et al. (2016)
    The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
    J Thorac Oncol, 12 (2), 194-207
    DOI 10.1016/j.jtho.2016.10.003, PubMed 27729297
  105. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS et al. (2016)
    Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
    Lancet Oncol, 17 (10), 1396-1408
    DOI 10.1016/S1470-2045(16)30214-5, PubMed 27569442
  106. Marques A, Rodrigues AM, Romeu JC, Ruano A, Barbosa AP, Simões E, Águas F, Canhão H, Alves JD, Lucas R, Branco JC, Laíns J, Mascarenhas M, Simões S, Tavares V, Lourenço O, da Silva JA (2016)
    Multidisciplinary Portuguese recommendations on DXA request and indication to treat in the prevention of fragility fractures
    Acta Reumatol Port, 41 (4), 305-321
    PubMed 27750276
  107. McGowan M, Hoven AS, Lund-Iversen M, Solberg S, Helland Å, Hirsch FR, Brustugun OT (2016)
    PIK3CA mutations as prognostic factor in squamous cell lung carcinoma
    Lung Cancer, 103, 52-57
    DOI 10.1016/j.lungcan.2016.11.018, PubMed 28024696
  108. Meltzer S, Kalanxhi E, Hektoen HH, Dueland S, Flatmark K, Redalen KR, Ree AH (2016)
    Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
    Oncotarget, 7 (23), 34907-17
    DOI 10.18632/oncotarget.8995, PubMed 27145458
  109. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
    Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
    Oncoimmunology, 5 (5), e1138199
    DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
  110. Mezheyeuski A, Bradic Lindh M, Guren TK, Dragomir A, Pfeiffer P, Kure EH, Ikdahl T, Skovlund E, Corvigno S, Strell C, Pietras K, Ponten F, Mulder J, Qvortrup C, Portyanko A, Tveit KM, Glimelius B, Sorbye H, Östman A (2016)
    Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
    Oncotarget, 7 (27), 41948-41958
    DOI 10.18632/oncotarget.9632, PubMed 27248825
  111. Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PDP, Dunning AM, Shah M, Luben R, Bojesen SE, Nordestgaard BG, Schoemaker M, Swerdlow A, García-Closas M, Figueroa J, Dörk T, Bogdanova NV, Hall P, Li J, Khusnutdinova E, Bermisheva M, Kristensen V, Borresen-Dale AL et al. (2016)
    Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
    Genet Med, 19 (5), 599-603
    DOI 10.1038/gim.2016.147, PubMed 27711073
  112. Murbraech K, Holte E, Broch K, Smeland KB, Holte H, Rösner A, Lund MB, Dalen H, Kiserud C, Aakhus S (2016)
    Impaired Right Ventricular Function in Long-Term Lymphoma Survivors
    J Am Soc Echocardiogr, 29 (6), 528-36
    DOI 10.1016/j.echo.2016.02.014, PubMed 27038515
  113. Murbraech K, Wethal T, Smeland KB, Holte H, Loge JH, Holte E, Rösner A, Dalen H, Kiserud CE, Aakhus S (2016)
    Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study
    JACC Cardiovasc Imaging, 9 (3), 230-9
    DOI 10.1016/j.jcmg.2015.06.028, PubMed 26897666
  114. Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, Wälchli S, Green MR, Trøen G, Liestøl K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R (2016)
    Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
    Blood, 129 (6), 759-770
    DOI 10.1182/blood-2016-05-718494, PubMed 28011673
  115. Nilsen TS, Thorsen L, Kirkegaard C, Ugelstad I, Fosså SD, Raastad T (2016)
    The effect of strength training on muscle cellular stress in prostate cancer patients on ADT
    Endocr Connect, 5 (2), 74-82
    DOI 10.1530/EC-15-0120, PubMed 27169606
  116. Nyman J, Hallqvist A, Lund JÅ, Brustugun OT, Bergman B, Bergström P, Friesland S, Lewensohn R, Holmberg E, Lax I (2016)
    SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
    Radiother Oncol, 121 (1), 1-8
    DOI 10.1016/j.radonc.2016.08.015, PubMed 27600155
  117. Nymoen DA, Slipicevic A, Holth A, Emilsen E, Hetland Falkenthal TE, Tropé CG, Reich R, Flørenes VA, Davidson B (2016)
    MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
    Hum Pathol, 54, 74-81
    DOI 10.1016/j.humpath.2016.03.010, PubMed 27063471
  118. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
    Novel fusion genes and chimeric transcripts in ependymal tumors
    Genes Chromosomes Cancer, 55 (12), 944-953
    DOI 10.1002/gcc.22392, PubMed 27401149
  119. Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
    A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
    Thyroid, 26 (9), 1225-38
    DOI 10.1089/thy.2015.0673, PubMed 27400880
  120. Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D (2016)
    Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
    Eur Urol, 70 (5), 875-883
    DOI 10.1016/j.eururo.2016.06.002, PubMed 27344296
  121. Pauly F, Fjordén K, Leppä S, Holte H, Björkholm M, Fluge Ø, Møller Pedersen L, Eriksson M, Isinger-Ekstrand A, Borrebaeck CA, Jerkeman M, Wingren C (2016)
    Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
    Blood Cancer J, 6 (11), e501
    DOI 10.1038/bcj.2016.113, PubMed 27858932
  122. Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
    Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
    Clin Nutr, 36 (3), 672-679
    DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859
  123. Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE (2016)
    Fatigue During and After Breast Cancer Therapy-A Prospective Study
    J Pain Symptom Manage, 53 (3), 551-560
    DOI 10.1016/j.jpainsymman.2016.09.011, PubMed 28042070
  124. Rud AK, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun OT, Mælandsmo GM (2016)
    Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
    Diagn Pathol, 11 (1), 50
    DOI 10.1186/s13000-016-0504-4, PubMed 27316334
  125. Røhrl K, Guren MG, Miaskowski C, Cooper BA, Diep LM, Rustøen T (2016)
    No Differences in Symptom Burden Between Colorectal Cancer Patients Receiving Curative Versus Palliative Chemotherapy
    J Pain Symptom Manage, 52 (4), 539-547
    DOI 10.1016/j.jpainsymman.2016.04.008, PubMed 27470003
  126. Sandhu V, Wedge DC, Bowitz Lothe IM, Labori KJ, Dentro SC, Buanes T, Skrede ML, Dalsgaard AM, Munthe E, Myklebost O, Lingjærde OC, Børresen-Dale AL, Ikdahl T, Van Loo P, Nord S, Kure EH (2016)
    The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
    Cancer Res, 76 (17), 5092-102
    DOI 10.1158/0008-5472.CAN-16-0658, PubMed 27488532
  127. Schive SW, Foss A, Sahraoui A, Kloster-Jensen K, Hafsahl G, Kvalheim G, Lundgren T, von Zur-Mühlen B, Felldin M, Rafael E, Lempinen M, Korsgren O, Jenssen TG, Mishra V, Scholz H (2016)
    Cost and clinical outcome of islet transplantation in Norway 2010-2015
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12871, PubMed 27862341
  128. Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frodin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Watkins DJ (2016)
    Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
    Int J Cancer, 140 (2), 431-439
    DOI 10.1002/ijc.30453, PubMed 27681944
  129. Sert BM, Boggess JF, Ahmad S, Jackson AL, Stavitzski NM, Dahl AA, Holloway RW (2016)
    Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer
    Eur J Surg Oncol, 42 (4), 513-22
    DOI 10.1016/j.ejso.2015.12.014, PubMed 26843445
  130. Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
    Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
    Case Rep Med, 2016, 9639585
    DOI 10.1155/2016/9639585, PubMed 27504122
  131. Sjøblom B, Benth JŠ, Grønberg BH, Baracos VE, Sawyer MB, Fløtten Ø, Hjermstad MJ, Aass N, Jordhøy M (2016)
    Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer
    Clin Lung Cancer, 18 (2), e129-e136
    DOI 10.1016/j.cllc.2016.09.008, PubMed 27825639
  132. Sjøblom B, Grønberg BH, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Bye A, Jordhøy M (2016)
    Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
    Clin Nutr, 35 (6), 1386-1393
    DOI 10.1016/j.clnu.2016.03.010, PubMed 27102408
  133. Sjøgren P, Kaasa S (2016)
    The role of opioids in cancer progression: emerging experimental and clinical implications
    Ann Oncol, 27 (11), 1978-1980
    DOI 10.1093/annonc/mdw407, PubMed 27573559
  134. Smeland KB, Kiserud CE, Lauritzsen GF, Blystad AK, Fagerli UM, Falk RS, Fluge Ø, Fosså A, Kolstad A, Loge JH, Maisenhölder M, Østenstad B, Kvaløy S, Holte H (2016)
    A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma
    Br J Haematol, 173 (3), 432-43
    DOI 10.1111/bjh.13965, PubMed 26914167
  135. Sommerbakk R, Haugen DF, Tjora A, Kaasa S, Hjermstad MJ (2016)
    Barriers to and facilitators for implementing quality improvements in palliative care - results from a qualitative interview study in Norway
    BMC Palliat Care, 15, 61
    DOI 10.1186/s12904-016-0132-5, PubMed 27422410
  136. Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy S, Thorsen L, Arbo I, Jones LW, Aakhus S, Lund MB, Kiserud CE (2016)
    Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation
    Br J Cancer, 115 (2), 178-87
    DOI 10.1038/bjc.2016.180, PubMed 27351215
  137. Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy S, Wethal T, Kiserud CE, Lund MB (2016)
    Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
    Bone Marrow Transplant, 52 (4), 646-649
    DOI 10.1038/bmt.2016.338, PubMed 27991891
  138. Strathmann FG, Travis LB, Ardeshirrouhanifard S, Fossa SD, Moody S, Clarke D, Law CL (2016)
    Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry
    J. Appl. Lab. Med., 1 (2), 143-151
  139. Sygna K, Johansen S, Ruland CM (2016)
    Erratum to: 'Recruitment challenges in clinical research including cancer patients and their caregivers. A randomized controlled trial study and lessons learned'
    Trials, 17 (1), 133
    DOI 10.1186/s13063-016-1276-6, PubMed 26965306
  140. Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
    Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
    Ann Oncol, 27 (7), 1299-304
    DOI 10.1093/annonc/mdw164, PubMed 27052649
  141. Tarpgaard LS, Ørum-Madsen MS, Christensen IJ, Nordgaard C, Noer J, Guren TK, Glimelius B, Sorbye H, Ikdahl T, Kure EH, Tveit KM, Nielsen HJ, Pfeiffer P, Brünner N, Moreira JM (2016)
    TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer
    Oncotarget, 7 (37), 59441-59457
    DOI 10.18632/oncotarget.11118, PubMed 27509063
  142. Thomas S, Walsh D, Shrotriya S, Aktas A, Hullihen B, Estfan B, Budd GT, Hjermstad MJ, O'Connor B (2016)
    Symptoms, Quality of Life, and Daily Activities in People With Newly Diagnosed Solid Tumors Presenting to a Medical Oncologist
    Am J Hosp Palliat Care, 34 (7), 611-621
    DOI 10.1177/1049909116649948, PubMed 27217423
  143. Thomsen M, Kersten C, Sorbye H, Skovlund E, Glimelius B, Pfeiffer P, Johansen JS, Kure EH, Ikdahl T, Tveit KM, Christoffersen T, Guren TK (2016)
    Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
    Oncotarget, 7 (46), 75013-75022
    DOI 10.18632/oncotarget.12601, PubMed 27738330
  144. Thorgersen EB, Goscinski MA, Spasojevic M, Solbakken AM, Mariathasan AB, Boye K, Larsen SG, Flatmark K (2016)
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer
    Ann Surg Oncol, 24 (3), 721-728
    DOI 10.1245/s10434-016-5621-5, PubMed 27766561
  145. Thorsen L, Dahl AA, Nystad R, Kiserud CE, Geirdal AØ, Smeland S (2016)
    Baseline characteristics in female cancer patients with unimproved work status after an outpatient rehabilitation program and health changes during the intervention
    Springerplus, 5 (1), 1009
    DOI 10.1186/s40064-016-2663-x, PubMed 27398282
  146. Torfoss D (2016)
    Carbapenems and febrile neutropenia - author's reply
    Clin Microbiol Infect, 23 (3), 214
    DOI 10.1016/j.cmi.2016.12.019, PubMed 28025133
  147. Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
    Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
    Clin Microbiol Infect, 23 (3), 179-187
    DOI 10.1016/j.cmi.2016.10.019, PubMed 27793737
  148. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  149. Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS (2016)
    Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
    Clin Sarcoma Res, 6, 2
    DOI 10.1186/s13569-016-0042-6, PubMed 26913180
  150. Varghese M, Nymoen HG, Saxhaug C, Krossnes B, Abdol Mohieb Hosainey S, Meling TR, Brandal P (2016)
    Symptomatic spinal metastasis from intracranial glioblastoma multiforme - Two illustrative cases and a review of the literature
    Acta Oncol, 55 (9-10), 1236-1238
    DOI 10.3109/0284186X.2016.1161824, PubMed 27174685
  151. Weischenfeldt J, Dubash T, Drainas AP, Mardin BR, Chen Y, Stütz AM, Waszak SM, Bosco G, Halvorsen AR, Raeder B, Efthymiopoulos T, Erkek S, Siegl C, Brenner H, Brustugun OT, Dieter SM, Northcott PA, Petersen I, Pfister SM, Schneider M, Solberg SK, Thunissen E, Weichert W, Zichner T, Thomas R et al. (2016)
    Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking
    Nat Genet, 49 (1), 65-74
    DOI 10.1038/ng.3722, PubMed 27869826
  152. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH (2016)
    Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
    PLoS One, 11 (10), e0165382
    DOI 10.1371/journal.pone.0165382, PubMed 27776176
  153. Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB (2016)
    Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
    Clin Cancer Res, 23 (13), 3325-3333
    DOI 10.1158/1078-0432.CCR-16-2809, PubMed 28039263
  154. Zecca E, Brunelli C, Bracchi P, Biancofiore G, De Sangro C, Bortolussi R, Montanari L, Maltoni M, Moro C, Colonna U, Finco G, Roy MT, Ferrari V, Alabiso O, Rosti G, Kaasa S, Caraceni A (2016)
    Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial
    J Pain Symptom Manage, 52 (6), 783-794.e6
    DOI 10.1016/j.jpainsymman.2016.05.030, PubMed 27742577
  155. Østby-Deglum M, Axcrona K, Brennhovd B, Dahl AA (2016)
    Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy
    Urology, 92, 38-43
    DOI 10.1016/j.urology.2015.11.066, PubMed 26972145

Publications 2015

  1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
    Gene Ther, 22 (5), 391-403
    DOI 10.1038/gt.2015.4, PubMed 25652098
  2. Andersson Y, Engebraaten O, Juell S, Aamdal S, Brunsvig P, Fodstad Ø, Dueland S (2015)
    Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
    Br J Cancer, 113 (11), 1548-55
    DOI 10.1038/bjc.2015.380, PubMed 26554649
  3. Anfinsen KP, Grotmol T, Bruland OS, Cathrine T, Jonasdottir TJ (2015)
    Corrigendum to "Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence" [Prev. Vet. Med. 119 (2015) 48-53]
    Prev Vet Med, 120 (2), 252
    DOI 10.1016/j.prevetmed.2015.03.015, PubMed 31159133
  4. Anfinsen KP, Grotmol T, Bruland OS, Trangerud C, Jonasdottir TJ (2015)
    Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence
    Prev Vet Med, 119 (1-2), 48-53
    DOI 10.1016/j.prevetmed.2015.02.003, PubMed 25732913
  5. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
    Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
    Acta Oncol, 54 (9), 1607-13
    DOI 10.3109/0284186X.2015.1061690, PubMed 26213311
  6. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
    Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy
    Pain, 156 (5), 967-79
    DOI 10.1097/j.pain.0000000000000142, PubMed 25719616
  7. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
    A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy
    Cancer Nurs, 38 (6), 436-46
    DOI 10.1097/NCC.0000000000000225, PubMed 25643005
  8. Aure MR, Jernström S, Krohn M, Vollan HK, Due EU, Rødland E, Kåresen R, Oslo Breast Cancer Research Consortium (OSBREAC), Ram P, Lu Y, Mills GB, Sahlberg KK, Børresen-Dale AL, Lingjærde OC, Kristensen VN (2015)
    Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
    Genome Med, 7 (1), 21
    DOI 10.1186/s13073-015-0135-5, PubMed 25873999
  9. Baekelandt BM, Hjermstad MJ, Nordby T, Fagerland MW, Kure EH, Heiberg T, Buanes T, Labori KJ (2015)
    Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma
    HPB (Oxford), 18 (3), 247-54
    DOI 10.1016/j.hpb.2015.09.004, PubMed 27017164
  10. Barrett ES, Chen C, Thurston SW, Haug LS, Sabaredzovic A, Fjeldheim FN, Frydenberg H, Lipson SF, Ellison PT, Thune I (2015)
    Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women
    Fertil Steril, 103 (5), 1261-70.e3
    DOI 10.1016/j.fertnstert.2015.02.001, PubMed 25747128
  11. Barrett ES, Tran V, Thurston SW, Frydenberg H, Lipson SF, Thune I, Ellison PT (2015)
    Women who are married or living as married have higher salivary estradiol and progesterone than unmarried women
    Am J Hum Biol, 27 (4), 501-7
    DOI 10.1002/ajhb.22676, PubMed 25753399
  12. Barzenje DA, Cvancarova Småstuen M, Liestøl K, Fosså A, Delabie J, Kolstad A, Holte H (2015)
    Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years
    PLoS One, 10 (7), e0131158
    DOI 10.1371/journal.pone.0131158, PubMed 26147646
  13. Berner K, Bjerkehagen B, Bruland ØS, Berner A (2015)
    Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature
    Anticancer Res, 35 (4), 2129-40
    PubMed 25862869
  14. Berner K, Hall KS, Monge OR, Weedon-Fekjær H, Zaikova O, Bruland ØS (2015)
    Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient
    Sarcoma, 2015, 516843
    DOI 10.1155/2015/516843, PubMed 25784831
  15. Berner K, Johannesen TB, Bruland ØS (2015)
    Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
    Sarcoma, 2015, 917679
    DOI 10.1155/2015/917679, PubMed 26412976
  16. Bjørklund SS, Kristensen VN, Seiler M, Kumar S, Alnæs GI, Ming Y, Kerrigan J, Naume B, Sachidanandam R, Bhanot G, Børresen-Dale AL, Ganesan S (2015)
    Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas
    BMC Cancer, 15, 524
    DOI 10.1186/s12885-015-1510-8, PubMed 26183823
  17. Bjørnslett M, Dahl AA, Sørebø Ø, Dørum A (2015)
    Psychological distress related to BRCA testing in ovarian cancer patients
    Fam Cancer, 14 (4), 495-504
    DOI 10.1007/s10689-015-9811-2, PubMed 25980896
  18. Bjaanæs MM, Fleischer T, Halvorsen AR, Daunay A, Busato F, Solberg S, Jørgensen L, Kure E, Edvardsen H, Børresen-Dale AL, Brustugun OT, Tost J, Kristensen V, Helland Å (2015)
    Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
    Mol Oncol, 10 (2), 330-43
    DOI 10.1016/j.molonc.2015.10.021, PubMed 26601720
  19. Blaker YN, Brodtkorb M, Maddison J, Hveem TS, Nesheim JA, Mohn HM, Kolstad A, Geisler CH, Liestøl K, Smeland EB, Holte H, Delabie J, Danielsen H (2015)
    Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma
    Histopathology, 67 (1), 62-9
    DOI 10.1111/his.12624, PubMed 25431344
  20. Blix ES, Kildal AB, Bertelsen E, Waage A, Myklebust JH, Kolstad A, Husebekk A (2015)
    Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma
    Biol Blood Marrow Transplant, 21 (5), 840-7
    DOI 10.1016/j.bbmt.2014.12.027, PubMed 25689789
  21. Brabrand S, Johannessen B, Axcrona U, Kraggerud SM, Berg KG, Bakken AC, Bruun J, Fosså SD, Lothe RA, Lehne G, Skotheim RI (2015)
    Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages
    Neoplasia, 17 (2), 167-74
    DOI 10.1016/j.neo.2014.12.005, PubMed 25748235
  22. Brudvik KW, Seeberg LT, Hugenschmidt H, Renolen A, Schirmer CB, Brunborg C, Bjørnbeth BA, Borgen E, Naume B, Waage A, Wiedswang G (2015)
    Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
    Ann Surg Oncol, 22 (12), 4029-37
    DOI 10.1245/s10434-015-4482-7, PubMed 25801354
  23. Brustugun OT (2015)
    [Re: In momentous development?]
    Tidsskr Nor Laegeforen, 135 (5), 413-4
    DOI 10.4045/tidsskr.15.0208, PubMed 25761018
  24. Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG (2015)
    Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study
    Radiother Oncol, 115 (3), 314-20
    DOI 10.1016/j.radonc.2015.05.021, PubMed 26091575
  25. Carling U, Dorenberg EJ, Haugvik SP, Eide NA, Berntzen DT, Edwin B, Dueland S, Røsok B (2015)
    Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications
    Cardiovasc Intervent Radiol, 38 (6), 1532-41
    DOI 10.1007/s00270-015-1093-4, PubMed 25832764
  26. Cehajic I, Bergan S, Bjordal K (2015)
    Pharmacist assessment of drug-related problems on an oncology ward
    Eur. J. Hosp. Pharm.-Sci. Pract., 22 (4), 194-197
  27. Christiansen JR, Kanellopoulos A, Lund MB, Massey R, Dalen H, Kiserud CE, Ruud E, Aakhus S (2015)
    Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia
    Pediatr Blood Cancer, 62 (8), 1437-43
    DOI 10.1002/pbc.25492, PubMed 25832752
  28. Dahl S, Cvancarova M, Dahl AA, Fosså SD (2015)
    Work ability in prostate cancer survivors after radical prostatectomy
    Scand J Urol, 50 (2), 116-22
    DOI 10.3109/21681805.2015.1100674, PubMed 26609896
  29. Dahl AA (2015)
    Re: Useful, but a bit boring
    Tidsskr. Nor. Laegeforen., 135 (17), 1534
  30. Darabi H, McCue K, Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, Hopper JL, Southey MC, Stone J, Broeks A, Schmidt MK, Scott RJ, Lophatananon A, Muir K, Beckmann MW, Ekici AB et al. (2015)
    Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
    Am J Hum Genet, 97 (1), 22-34
    DOI 10.1016/j.ajhg.2015.05.002, PubMed 26073781
  31. Donnem T, Hald SM, Paulsen EE, Richardsen E, Al-Saad S, Kilvaer TK, Brustugun OT, Helland A, Lund-Iversen M, Poehl M, Olsen KE, Ditzel HJ, Hansen O, Al-Shibli K, Kiselev Y, Sandanger TM, Andersen S, Pezzella F, Bremnes RM, Busund LT (2015)
    Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
    Clin Cancer Res, 21 (11), 2635-43
    DOI 10.1158/1078-0432.CCR-14-1905, PubMed 25680376
  32. Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, Al-Saad S, Brustugun OT, Helland A, Lund-Iversen M, Solberg S, Gronberg BH, Wahl SG, Helgeland L, Fløtten O, Pohl M, Al-Shibli K, Sandanger TM, Pezzella F, Busund LT, Bremnes RM (2015)
    Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
    Ann Oncol, 27 (2), 225-32
    DOI 10.1093/annonc/mdv560, PubMed 26578726
  33. Due-Tønnessen BJ, Egge A, Lundar T, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
    Springerplus, 4, 389
    DOI 10.1186/s40064-015-1178-1, PubMed 26251773
  34. Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, Foss A, Tveit KM (2015)
    Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?
    Ann Surg, 261 (5), 956-60
    DOI 10.1097/SLA.0000000000000786, PubMed 24950280
  35. Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM (2015)
    Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
    Clin Exp Metastasis, 32 (8), 755-67
    DOI 10.1007/s10585-015-9742-1, PubMed 26349943
  36. Eide N, Faye RS, Høifødt HK, Sandstad B, Qvale G, Faber R, Jebsen P, Kvalheim G, Fodstad Ø (2015)
    Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox
    Acta Ophthalmol, 93 (1), 59-66
    DOI 10.1111/aos.12462, PubMed 25613126
  37. Erdei T, Aakhus S, Marino P, Paulus WJ, Smiseth OA, Fraser AG (2015)
    Pathophysiological rationale and diagnostic targets for diastolic stress testing
    Heart, 101 (17), 1355-60
    DOI 10.1136/heartjnl-2014-307040, PubMed 26001845
  38. Fauske L, Bondevik H, Bruland ØS, Ozakinci G (2015)
    Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study
    Anticancer Res, 35 (11), 6081-90
    PubMed 26504033
  39. Fauske L, Bruland OS, Grov EK, Bondevik H (2015)
    Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities
    Sarcoma, 2015, 484196
    DOI 10.1155/2015/484196, PubMed 25949211
  40. Fauske L, Lorem G, Grov EK, Bondevik H (2015)
    Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study
    J Surg Oncol, 113 (2), 229-34
    DOI 10.1002/jso.24138, PubMed 26714610
  41. Fernandez-Cuesta L, Sun R, Menon R, George J, Lorenz S, Meza-Zepeda LA, Peifer M, Plenker D, Heuckmann JM, Leenders F, Zander T, Dahmen I, Koker M, Schöttle J, Ullrich RT, Altmüller J, Becker C, Nürnberg P, Seidel H, Böhm D, Göke F, Ansén S, Russell PA, Wright GM, Wainer Z et al. (2015)
    Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data
    Genome Biol, 16, 7
    DOI 10.1186/s13059-014-0558-0, PubMed 25650807
  42. Ferrari S, Luksch R, Hall KS, Fagioli F, Prete A, Tamburini A, Tienghi A, DiGirolamo S, Paioli A, Abate ME, Podda M, Cammelli S, Eriksson M, Brach del Prever A (2015)
    Post-relapse survival in patients with Ewing sarcoma
    Pediatr Blood Cancer, 62 (6), 994-9
    DOI 10.1002/pbc.25388, PubMed 25585917
  43. Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT, Wist EA, Egeland T, Wilsgaard T, McTiernan A, Furberg AS, Thune I (2015)
    High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women
    Cancer Prev Res (Phila), 8 (6), 535-44
    DOI 10.1158/1940-6207.CAPR-14-0267, PubMed 25804612
  44. Fosså SD, Dahl AA (2015)
    Global Quality of Life After Curative Treatment for Prostate Cancer: What Matters? A Study Among Members of the Norwegian Prostate Cancer Patient Association
    Clin Genitourin Cancer, 13 (6), 518-24
    DOI 10.1016/j.clgc.2015.07.004, PubMed 26303590
  45. Fosså SD, Dahl AA, Langhammer A, Weedon-Fekjær H (2015)
    Cancer patients' participation in population-based health surveys: findings from the HUNT studies
    BMC Res Notes, 8, 649
    DOI 10.1186/s13104-015-1635-5, PubMed 26541408
  46. Frydenberg H, Flote VG, Larsson IM, Barrett ES, Furberg AS, Ursin G, Wilsgaard T, Ellison PT, McTiernan A, Hjartåker A, Jasienska G, Thune I (2015)
    Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women
    Breast Cancer Res, 17, 103
    DOI 10.1186/s13058-015-0620-1, PubMed 26246001
  47. Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB (2015)
    Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
    J Clin Oncol, 33 (28), 3105-15
    DOI 10.1200/JCO.2014.60.3654, PubMed 26240226
  48. Fung C, Fossa SD, Williams A, Travis LB (2015)
    Long-term Morbidity of Testicular Cancer Treatment
    Urol Clin North Am, 42 (3), 393-408
    DOI 10.1016/j.ucl.2015.05.002, PubMed 26216826
  49. George J, Lim JS, Jang SJ, Cun Y, Ozretić L, Kong G, Leenders F, Lu X, Fernández-Cuesta L, Bosco G, Müller C, Dahmen I, Jahchan NS, Park KS, Yang D, Karnezis AN, Vaka D, Torres A, Wang MS, Korbel JO, Menon R, Chun SM, Kim D, Wilkerson M, Hayes N et al. (2015)
    Comprehensive genomic profiles of small cell lung cancer
    Nature, 524 (7563), 47-53
    DOI 10.1038/nature14664, PubMed 26168399
  50. Gjerset GM, Loge JH, Gudbergsson SB, Bye A, Fosså SD, Oldervoll LM, Kiserud CE, Demark-Wahnefried W, Thorsen L (2015)
    Lifestyles of cancer survivors attending an inpatient educational program-a cross-sectional study
    Support Care Cancer, 24 (4), 1527-36
    DOI 10.1007/s00520-015-2936-x, PubMed 26370221
  51. Gouveia N, Rodrigues AM, Ramiro S, Machado P, da Costa LP, Mourão AF, Silva I, Rego T, Laires P, André R, Mauricio L, Romeu JC, Tavares V, Cerol J, Canhão H, Branco JC (2015)
    EpiReumaPt: how to perform a national population based study - a practical guide
    Acta Reumatol Port, 40 (2), 128-36
    PubMed 26219966
  52. Grønberg BH, Halvorsen TO, Fløtten Ø, Brustugun OT, Brunsvig PF, Aasebø U, Bremnes RM, Tollåli T, Hornslien K, Aksnessæther BY, Liaaen ED, Sundstrøm S, Norwegian Lung Cancer Study Group (2015)
    Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer
    Acta Oncol, 55 (5), 591-7
    DOI 10.3109/0284186X.2015.1092584, PubMed 26494411
  53. Gudbergsson SB, Dahl AA, Loge JH, Thorsen L, Oldervoll LM, Grov EK (2015)
    What is covered by "cancer rehabilitation" in PubMed? A review of randomized controlled trials 1990-2011
    J Rehabil Med, 47 (2), 97-106
    DOI 10.2340/16501977-1902, PubMed 25296993
  54. Gupta S, Argilés G, Munster PN, Hollebecque A, Dajani O, Cheng JD, Wang R, Swift A, Tosolini A, Piha-Paul SA (2015)
    A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies
    Clin Cancer Res, 21 (23), 5235-44
    DOI 10.1158/1078-0432.CCR-15-0180, PubMed 26187616
  55. Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015)
    Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010
    Acta Oncol, 54 (10), 1714-22
    DOI 10.3109/0284186X.2015.1034876, PubMed 25924970
  56. Hansen GL, Gaudernack G, Brunsvig PF, Cvancarova M, Kyte JA (2015)
    Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
    Cancer Immunol Immunother, 64 (12), 1609-21
    DOI 10.1007/s00262-015-1766-5, PubMed 26498005
  57. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2015)
    Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
    Ann Surg Oncol, 22 (12), 3836-45
    DOI 10.1245/s10434-015-4441-3, PubMed 25743325
  58. Hauge T, Hauge PW, Warloe T, Drolsum A, Johansen C, Viktil E, Aabakken L, Buanes T, Konopski Z (2015)
    Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study
    Photodiagnosis Photodyn Ther, 13, 330-333
    DOI 10.1016/j.pdpdt.2015.09.004, PubMed 26415549
  59. Hektoen HH, Flatmark K, Andersson Y, Dueland S, Redalen KR, Ree AH (2015)
    Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
    BMC Cancer, 15, 543
    DOI 10.1186/s12885-015-1557-6, PubMed 26205955
  60. Helland A (2015)
    Cancer stem cells
    Tidsskr. Nor. Laegeforen., 135 (8), 783
  61. Helland A (2015)
    Gene jockeys Life science and the rise of biotech enterprise.
    Tidsskr. Nor. Laegeforen., 135 (4), 356
  62. Helland A (2015)
    Viruses and human cancer
    Tidsskr. Nor. Laegeforen., 135 (9), 874
  63. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2015)
    Prevalence and predictors of persistent post-surgical pain 12 months after thoracotomy
    Acta Anaesthesiol Scand, 59 (6), 740-8
    DOI 10.1111/aas.12532, PubMed 25907109
  64. Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS (2015)
    Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study
    Anticancer Res, 35 (3), 1619-25
    PubMed 25750319
  65. Hompland I, Bruland ØS (2015)
    Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
    Anticancer Res, 35 (11), 5759-65
    PubMed 26503996
  66. Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS (2015)
    [A boy with a wound on his finger that would not heal]
    Tidsskr Nor Laegeforen, 135 (5), 445-8
    DOI 10.4045/tidsskr.14.0759, PubMed 25761032
  67. Hompland I, Rizvi SMH, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mork NJ, Hall KS (2015)
    A boy with a wound on his finger that would not heal
    Tidsskr. Nor. Laegeforen., 135 (5), 444-447
  68. Hoster E, Geisler CH, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans JC, Klapper W, Unterhalt M, Dreyling M, Hermine O (2015)
    Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials
    Leukemia, 30 (6), 1428-30
    DOI 10.1038/leu.2015.322, PubMed 26598017
  69. Humm JL, Sartor O, Parker C, Bruland OS, Macklis R (2015)
    Radium-223 in the treatment of osteoblastic metastases: a critical clinical review
    Int J Radiat Oncol Biol Phys, 91 (5), 898-906
    DOI 10.1016/j.ijrobp.2014.12.061, PubMed 25832684
  70. Haakensen VD, Steinfeld I, Saldova R, Shehni AA, Kifer I, Naume B, Rudd PM, Børresen-Dale AL, Yakhini Z (2015)
    Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome
    Mol Oncol, 10 (1), 59-72
    DOI 10.1016/j.molonc.2015.08.002, PubMed 26321095
  71. Jabeen S, Holmboe L, Alnæs GI, Andersen AM, Hall KS, Kristensen VN (2015)
    Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
    Pharmacogenomics J, 15 (5), 385-90
    DOI 10.1038/tpj.2015.11, PubMed 25778468
  72. Janberidze E, Pereira SM, Hjermstad MJ, Knudsen AK, Kaasa S, van der Heide A, Onwuteaka-Philipsen B, EURO IMPACT (2015)
    Depressive symptoms in the last days of life of patients with cancer: a nationwide retrospective mortality study
    BMJ Support Palliat Care, 6 (2), 201-9
    DOI 10.1136/bmjspcare-2014-000722, PubMed 25669202
  73. Jasienska G, Ellison PT, Galbarczyk A, Jasienski M, Kalemba-Drozdz M, Kapiszewska M, Nenko I, Thune I, Ziomkiewicz A (2015)
    Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: a case of antagonistic pleiotropy?
    Proc Biol Sci, 282 (1803), 20142395
    DOI 10.1098/rspb.2014.2395, PubMed 25673673
  74. Johansen N, Liavaag AH, Tanbo TG, Dahl AA, Pripp AH, Michelsen TM (2015)
    Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy
    Gynecol Oncol, 140 (1), 101-6
    DOI 10.1016/j.ygyno.2015.11.016, PubMed 26597462
  75. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM (2015)
    F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study
    Clin Physiol Funct Imaging, 36 (6), 441-446
    DOI 10.1111/cpf.12247, PubMed 26039107
  76. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
  77. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
  78. Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB, Westlye LT, Fosså SD, Ruud E (2015)
    Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only
    Pediatr Blood Cancer, 63 (1), 133-8
    DOI 10.1002/pbc.25690, PubMed 26312396
  79. Kasenda B, Ferreri AJ, Marturano E, Forst D, Bromberg J, Ghesquieres H, Ferlay C, Blay JY, Hoang-Xuan K, Pulczynski EJ, Fosså A, Okoshi Y, Chiba S, Fritsch K, Omuro A, O'Neill BP, Bairey O, Schandelmaier S, Gloy V, Bhatnagar N, Haug S, Rahner S, Batchelor TT, Illerhaus G, Briel M (2015)
    First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis
    Ann Oncol, 26 (7), 1305-13
    DOI 10.1093/annonc/mdv076, PubMed 25701456
  80. Kimby E, Östenstad B, Brown P, Hagberg H, Erlanson M, Holte H, Linden O, Johansson AS, Ahlgren T, Wader K, Wahlin BE, Delabie J, Sundström C, Nordic Lymphoma Group (NLG) (2015)
    Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas
    Leuk Lymphoma, 56 (9), 2598-607
    DOI 10.3109/10428194.2015.1014363, PubMed 25686644
  81. Kirkhus L, Jordhøy M, Šaltytė Benth J, Rostoft S, Selbæk G, Jensen Hjermstad M, Grønberg BH (2015)
    Comparing comorbidity scales: Attending physician score versus the Cumulative Illness Rating Scale for Geriatrics
    J Geriatr Oncol, 7 (2), 90-8
    DOI 10.1016/j.jgo.2015.12.003, PubMed 26739557
  82. Kjersem JB, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit KM, Wettergren Y, Kure EH (2015)
    AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin
    Pharmacogenomics J, 16 (3), 272-9
    DOI 10.1038/tpj.2015.54, PubMed 26261061
  83. Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
    Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
    Eur J Surg Oncol, 41 (7), 920-6
    DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010
  84. Klimek M, Galbarczyk A, Colleran H, Thune I, Ellison PT, Ziomkiewicz A, Jasienska G (2015)
    Digit ratio (2D:4D) does not correlate with daily 17β-estradiol and progesterone concentrations in healthy women of reproductive age
    Am J Hum Biol, 27 (5), 667-73
    DOI 10.1002/ajhb.22717, PubMed 25833729
  85. Knappskog S, Berge EO, Chrisanthar R, Geisler S, Staalesen V, Leirvaag B, Yndestad S, de Faveri E, Karlsen BO, Wedge DC, Akslen LA, Lilleng PK, Løkkevik E, Lundgren S, Østenstad B, Risberg T, Mjaaland I, Aas T, Lønning PE (2015)
    Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo
    Mol Oncol, 9 (8), 1553-64
    DOI 10.1016/j.molonc.2015.04.008, PubMed 26004085
  86. Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
    Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
    Mol Oncol, 9 (6), 1129-39
    DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404
  87. Koller M, Warncke S, Hjermstad MJ, Arraras J, Pompili C, Harle A, Johnson CD, Chie WC, Schulz C, Zeman F, van Meerbeeck JP, Kuliś D, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, EORTC Lung Cancer Group (2015)
    Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development
    Cancer, 121 (24), 4300-23
    DOI 10.1002/cncr.29682, PubMed 26451520
  88. Kolstad A, Olweus J (2015)
    "In situ" vaccination for systemic effects in follicular lymphoma
    Oncoimmunology, 4 (7), e1014773
    DOI 10.1080/2162402X.2015.1014773, PubMed 26140239
  89. Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, Fosså SD, Adami HO, Turnbull C, Haugen TB, Grotmol T, Wiklund F (2015)
    Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
    Hum Mol Genet, 24 (14), 4138-46
    DOI 10.1093/hmg/ddv129, PubMed 25877299
  90. Kåresen R, Lunde C (2015)
    [Not Available]
    Tidsskr Nor Laegeforen, 135 (23-24), 2148-50
    DOI 10.4045/tidsskr.15.1176, PubMed 26674034
  91. Labori KJ, Katz MH, Tzeng CW, Bjørnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP (2015)
    Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
    Acta Oncol, 55 (3), 265-77
    DOI 10.3109/0284186X.2015.1068445, PubMed 26213211
  92. Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA (2015)
    Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center
    Acta Radiol Open, 4 (7), 2058460115580877
    DOI 10.1177/2058460115580877, PubMed 26346740
  93. Leon O, Guren MG, Radu C, Gunnlaugsson A, Johnsson A (2015)
    Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer
    Eur J Cancer, 51 (18), 2740-6
    DOI 10.1016/j.ejca.2015.08.029, PubMed 26597443
  94. Lie HC, Loge JH, Fosså SD, Hamre HM, Hess SL, Mellblom AV, Ruud E, Finset A (2015)
    Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when
    Patient Educ Couns, 98 (5), 604-11
    DOI 10.1016/j.pec.2015.01.016, PubMed 25704291
  95. Lilleby W, Narrang A, Tafjord G, Vlatkovic L, Russnes KM, Stensvold A, Hole KH, Tran P, Eilertsen K (2015)
    Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
    Radiat Oncol, 10, 232
    DOI 10.1186/s13014-015-0540-3, PubMed 26577452
  96. Lilleby W, Raabe NK, Normann M (2015)
    [Re: The problematical prostate cancer]
    Tidsskr Nor Laegeforen, 135 (11), 1009
    DOI 10.4045/tidsskr.15.0593, PubMed 26080763
  97. Line PD, Hagness M, Berstad AE, Foss A, Dueland S (2015)
    A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases: The RAPID Concept
    Ann Surg, 262 (1), e5-9
    DOI 10.1097/SLA.0000000000001165, PubMed 25692361
  98. Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, von Minckwitz G, Parokonnaya A, Stensheim H, Thomssen C, van Calsteren K, Poortmans P, Berveiller P, Markert UR, Amant F (2015)
    Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients
    JAMA Oncol, 1 (8), 1145-53
    DOI 10.1001/jamaoncol.2015.2413, PubMed 26247818
  99. Lund-Iversen M, Grøholt KK, Helland Å, Borgen E, Brustugun OT (2015)
    NUT expression in primary lung tumours
    Diagn Pathol, 10, 156
    DOI 10.1186/s13000-015-0395-9, PubMed 26341600
  100. Lundar T, Due-Tønnessen BJ, Egge A, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
    Childs Nerv Syst, 31 (12), 2283-90
    DOI 10.1007/s00381-015-2792-5, PubMed 26174616
  101. Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR, Overgaard J (2015)
    The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
    Radiother Oncol, 117 (1), 91-8
    DOI 10.1016/j.radonc.2015.07.004, PubMed 26255764
  102. Löffeler S, Weedon-Fekjaer H, Wang-Hansen MS, Sebakk K, Hamre H, Haug ES, Fosså SD (2015)
    "Natural course" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment
    Scand J Urol, 49 (6), 440-445
    DOI 10.3109/21681805.2015.1059881, PubMed 26139461
  103. Malecka A, Tierens A, Østlie I, Schmitz R, Trøen G, Spetalen S, Staudt LM, Smeland E, Holte H, Delabie J (2015)
    Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell
    Haematologica, 100 (10), e415-8
    DOI 10.3324/haematol.2015.126656, PubMed 26001788
  104. Marcinkowska UM, Ellison PT, Galbarczyk A, Milkowska K, Pawlowski B, Thune I, Jasienska G (2015)
    Lack of support for relation between woman's masculinity preference, estradiol level and mating context
    Horm Behav, 78, 1-7
    DOI 10.1016/j.yhbeh.2015.10.012, PubMed 26497247
  105. Mellblom AV, Korsvold L, Finset A, Loge J, Ruud E, Lie HC (2015)
    Providing Information About Late Effects During Routine Follow-Up Consultations Between Pediatric Oncologists and Adolescent Survivors: A Video-Based, Observational Study
    J Adolesc Young Adult Oncol, 4 (4), 200-8
    DOI 10.1089/jayao.2015.0037, PubMed 26697269
  106. Mellblom AV, Korsvold L, Ruud E, Lie HC, Loge JH, Finset A (2015)
    Sequences of talk about emotional concerns in follow-up consultations with adolescent childhood cancer survivors
    Patient Educ Couns, 99 (1), 77-84
    DOI 10.1016/j.pec.2015.07.021, PubMed 26265504
  107. Murbraech K, Smeland KB, Holte H, Loge JH, Lund MB, Wethal T, Holte E, Rösner A, Dalen H, Kvaløy S, Falk RS, Aakhus S, Kiserud CE (2015)
    Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study
    J Clin Oncol, 33 (24), 2683-91
    DOI 10.1200/JCO.2015.60.8125, PubMed 26169610
  108. Murbraech K, Solheim O, Aulie HM, Fossa SD, Aakhus S (2015)
    The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer
    ESC Heart Fail, 2 (3), 142-149
    DOI 10.1002/ehf2.12048, PubMed 28834675
  109. Naderi EH, Skah S, Ugland H, Myklebost O, Sandnes DL, Torgersen ML, Josefsen D, Ruud E, Naderi S, Blomhoff HK (2015)
    Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death
    Mol Cancer, 14, 14
    DOI 10.1186/s12943-014-0278-9, PubMed 25623255
  110. Narud K, Dahl AA (2015)
    Stalking experiences reported by Norwegian members of Parliament compared to a population sample
    J. Forensic Psychiatry Psychol., 26 (1), 116-131
  111. Nielsen HM, How-Kit A, Guerin C, Castinetti F, Vollan HK, De Micco C, Daunay A, Taieb D, Van Loo P, Besse C, Kristensen VN, Hansen LL, Barlier A, Sebag F, Tost J (2015)
    Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors
    Endocr Relat Cancer, 22 (6), 953-67
    DOI 10.1530/ERC-15-0086, PubMed 26400872
  112. Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L (2015)
    Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy
    Acta Oncol, 54 (10), 1805-13
    DOI 10.3109/0284186X.2015.1037008, PubMed 25927504
  113. Nilsen TS, Thorsen L, Fosså SD, Wiig M, Kirkegaard C, Skovlund E, Benestad HB, Raastad T (2015)
    Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy
    Scand J Med Sci Sports, 26 (9), 1026-35
    DOI 10.1111/sms.12543, PubMed 26282343
  114. Nilssen Y, Strand TE, Fjellbirkeland L, Bartnes K, Brustugun OT, O'Connell DL, Yu XQ, Møller B (2015)
    Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage
    Int J Cancer, 138 (6), 1350-60
    DOI 10.1002/ijc.29875, PubMed 26421593
  115. Nymoen DA, Hetland Falkenthal TE, Holth A, Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC, Davidson B (2015)
    Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma
    Gynecol Oncol, 139 (1), 30-9
    DOI 10.1016/j.ygyno.2015.07.107, PubMed 26232338
  116. Nymoen DA, Holth A, Hetland Falkenthal TE, Tropé CG, Davidson B (2015)
    CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
    Mol Cancer, 14, 44
    DOI 10.1186/s12943-015-0317-1, PubMed 25889687
  117. Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
    Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Neuro Oncol, 17 (10), 1365-73
    DOI 10.1093/neuonc/nov039, PubMed 25795305
  118. Olssøn I, Svindseth MF, Dahl AA (2015)
    Is there an association between the level of grandiose narcissism severity of psychopathology?
    Nord J Psychiatry, 70 (2), 121-7
    DOI 10.3109/08039488.2015.1058418, PubMed 26212624
  119. Ozguven BY, Tuncel D, Polat N, Sakiz D, Kabukcuoglu F, Koksal H, Kaya H (2015)
    Solid-pseudopapillary neoplasm of the pancreas: Clinicopathologic and immunohistochemical analysis of nine cases
    Indian J Pathol Microbiol, 58 (3), 292-5
    DOI 10.4103/0377-4929.162833, PubMed 26275248
  120. Paulsen Ø, Aass N, Klepstad P, Kaasa S (2015)
    Reply to a. Molfino et Al
    J Clin Oncol, 33 (13), 1513
    DOI 10.1200/JCO.2014.60.6475, PubMed 25753433
  121. Petersen MA, Aaronson NK, Chie WC, Conroy T, Costantini A, Hammerlid E, Hjermstad MJ, Kaasa S, Loge JH, Velikova G, Young T, Groenvold M (2015)
    Development of an item bank for computerized adaptive test (CAT) measurement of pain
    Qual Life Res, 25 (1), 1-11
    DOI 10.1007/s11136-015-1069-5, PubMed 26267524
  122. Pfister NT, Fomin V, Regunath K, Zhou JY, Zhou W, Silwal-